AURC
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NKT7 | S1482 | Sugiyama | RGPD3 RGP3 | DEAKTAQEKDsLItPHVsRsstPREsPCGKIAVAVLEEtTR |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| O00299 | S211 | Sugiyama | CLIC1 G6 NCC27 | CKKYRGFTIPEAFRGVHRYLsNAyAREEFAstCPDDEEIEL |
| O00458 | S14 | Sugiyama | IFRD1 | _______MPKNKKRNtPHRGssAGGGGsGAAAATAATAGGQ |
| O00469 | S597 | Sugiyama | PLOD2 | DELVEEMEHyGKWSGGKHHDsRIsGGyENVPTDDIHMKQVD |
| O00469 | S600 | Sugiyama | PLOD2 | VEEMEHyGKWSGGKHHDsRIsGGyENVPTDDIHMKQVDLEN |
| O00571 | S594 | Sugiyama | DDX3X DBX DDX3 | MAyEHHyKGssRGRSKssRFsGGFGARDYRQssGAssssFs |
| O00571 | S605 | Sugiyama | DDX3X DBX DDX3 | RGRSKssRFsGGFGARDYRQssGAssssFsssRAsSsRSGG |
| O00571 | S71 | Sugiyama | DDX3X DBX DDX3 | GFyDKDSSGWsssKDKDAyssFGsRsDsRGKssFFsDRGsG |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14618 | S267 | Sugiyama | CCS | DGLTIWEERGRPIAGKGRKEsAQPPAHL_____________ |
| O14715 | S1481 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | DEAKTAQEKDsLItPHVsRsstPREsPCGKIAVAVLEEITR |
| O14732 | S160 | Sugiyama | IMPA2 IMP.18P | RLYTGRRGRGAFCNGQRLRVsGETDLSKALVLTEIGPKRDP |
| O14907 | S61 | Sugiyama | TAX1BP3 TIP1 | PSQNPFSEDKTDKGIYVtRVsEGGPAEIAGLQIGDKIMQVN |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15013 | S1232 | Sugiyama | ARHGEF10 KIAA0294 | VKFIVLATALHEKDKDKsRDsLAPGPEPQDEDQKDALPSGG |
| O15037 | S291 | Sugiyama | KHNYN KIAA0323 | GWKELPGEEAWEREVALRPQsVGGGAREsAPLKGKALGKEE |
| O15037 | S299 | Sugiyama | KHNYN KIAA0323 | EAWEREVALRPQsVGGGAREsAPLKGKALGKEEIALGGGGF |
| O15067 | S1053 | Sugiyama | PFAS KIAA0361 | RGLRERMGPSYCLPPTFPKAsVPREPGGPsPRVAILREEGS |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15143 | S328 | Sugiyama | ARPC1B ARC41 | KAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTT |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15372 | S290 | Sugiyama | EIF3H EIF3S3 | QQQQKHQYQQRRQQENMQRQsRGEPPLPEEDLsKLFKPPQP |
| O15392 | S20 | EPSD|PSP | BIRC5 API4 IAP4 | _MGAPTLPPAWQPFLKDHRIstFKNWPFLEGCACtPERMAE |
| O15523 | S592 | Sugiyama | DDX3Y DBY | MAyEHHyKGGSRGRSKSNRFsGGFGARDYRQSSGSSSSGFG |
| O15523 | S71 | Sugiyama | DDX3Y DBY | GFHDKDSSGWSCSKDKDAyssFGsRDSRGKPGYFSERGSGS |
| O43175 | S166 | Sugiyama | PHGDH PGDH3 | KtLGILGLGRIGREVATRMQsFGMKTIGYDPIISPEVSASF |
| O43237 | S383 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | LMKQQSLLAKQPATPtRAsEsPARGPsGsPRTQGRGGPAsV |
| O43237 | S389 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | LLAKQPATPtRAsEsPARGPsGsPRTQGRGGPAsVPsssPG |
| O43237 | T378 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | DEQVFLMKQQSLLAKQPATPtRAsEsPARGPsGsPRTQGRG |
| O43823 | S124 | Sugiyama | AKAP8 AKAP95 | SKEGGRGGsGGGGEGIQDREssFRFQPFESYDSRPCLPEHN |
| O43847 | S94 | Sugiyama | NRDC NRD1 | ENSRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYR |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60739 | T46 | Sugiyama | EIF1B | GTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKKK |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O75116 | S762 | Sugiyama | ROCK2 KIAA0619 | EERTLKQKVENLLLEAEKRCsLLDCDLKQSQQKINELLKQK |
| O75157 | S205 | Sugiyama | TSC22D2 KIAA0669 TILZ4 | yYERDSDSSVLTRSGDCIRHssTFDQTAERDSGLGATGGSV |
| O75369 | S458 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | PKsPFVVQVGEACNPNACRAsGRGLQPKGVRIRETTDFKVD |
| O75396 | S137 | Sugiyama | SEC22B SEC22L1 | TFIQKTKKLYIDSRARRNLGsINtELQDVQRIMVANIEEVL |
| O75410 | S228 | SIGNOR|EPSD|PSP | TACC1 KIAA1103 | SAEADLKAGNsCPELVPSRRsKLRKPKPVPLRKKAIGGEFs |
| O75534 | S782 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | LDDAsAPRLMVLRQPRGPDNsMGFGAERKIRQAGVID____ |
| O75665 | S899 | Sugiyama | OFD1 CXorf5 | EEKIREQQVKERRQREERRQsNLQEVLERERRELEKLyQER |
| O95155 | S79 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | NMtPAtsPIGASGVAHRsQssEGVssLsssPsNsLEtQsQs |
| O95263 | S428 | Sugiyama | PDE8B PIG22 | FRYKNRRKESIDVKSISSRGsDAPSLQNRRYPSMARIHsMt |
| O95336 | T74 | Sugiyama | PGLS | LARELPAAVAPAGPASLARWtLGFCDERLVPFDHAEStyGL |
| O95456 | S180 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | KNMQITILTCRHVTDYKTSEsTGsLPsPFLRALKTQNFKDS |
| O95456 | S183 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | QITILTCRHVTDYKTSEsTGsLPsPFLRALKTQNFKDSACC |
| O95817 | S194 | Sugiyama | BAG3 BIS | PAAsDCsssSsSAsLPssGRssLGsHQLPRGyISIPVIHEQ |
| O95831 | S100 | Sugiyama | AIFM1 AIF PDCD8 | AGAYAYKTMKEDEKRyNERIsGLGLtPEQKQKKAALsAsEG |
| O95881 | T159 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | yFyVsAEQVVQGMKEAQERLtGDAFRKKHLEDEL_______ |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00491 | S163 | Sugiyama | PNP NP | GQNPLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGE |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00568 | S58 | Sugiyama | AK1 | stGDLLRSEVSSGSARGKKLsEIMEKGQLVPLETVLDMLRD |
| P02545 | S437 | Sugiyama | LMNA LMN1 | KKRKLEstEsRssFsQHARtsGRVAVEEVDEEGKFVRLRNK |
| P02545 | S463 | Sugiyama | LMNA LMN1 | EEVDEEGKFVRLRNKsNEDQsMGNWQIKRQNGDDPLLtYRF |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05783 | S177 | Sugiyama | KRT18 CYK18 PIG46 | ARLAADDFRVKyETELAMRQsVENDIHGLRKVIDDTNItRL |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P05787 | S34 | Sugiyama | KRT8 CYK8 | TSGPRAFSSRsYTSGPGSRIsSSSFSRVGSSNFRGGLGGGY |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | S273 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | IKtHILLFLPKSVSDYDGKLsNFKTAAEsFKGKILFIFIDS |
| P07237 | T340 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LEEEMTKyKPEsEELtAERItEFCHRFLEGKIKPHLMsQEL |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07737 | S57 | Sugiyama | PFN1 | GKtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDs |
| P07737 | S58 | Sugiyama | PFN1 | KtFVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsL |
| P07737 | S72 | Sugiyama | PFN1 | VGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFsMDLRtKs |
| P07737 | S77 | Sugiyama | PFN1 | ssFyVNGLtLGGQKCsVIRDsLLQDGEFsMDLRtKstGGAP |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07814 | S1473 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | CEDWIKKtTARDQDLEPGAPsMGAKSLCIPFKPLCELQPGA |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S164 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGT |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S623 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tyGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsII |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | T171 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTKVILHLK |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08174 | S54 | Sugiyama | CD55 CR DAF | GDCGLPPDVPNAQPALEGRTsFPEDtVItyKCEEsFVKIPG |
| P08238 | S159 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGT |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T166 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTKVILHLK |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | S116 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | LKHALKGAGTNEKVLtEIIAsRtPEELRAIKQVyEEEyGss |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P08865 | S75 | Sugiyama | RPSA LAMBR LAMR1 | WEKLLLAARAIVAIENPADVsVIssRNtGQRAVLKFAAAtG |
| P08865 | T82 | Sugiyama | RPSA LAMBR LAMR1 | ARAIVAIENPADVsVIssRNtGQRAVLKFAAAtGAtPIAGR |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09525 | S125 | Sugiyama | ANXA4 ANX4 | DEGCLIEILASRTPEEIRRIsQtYQQQYGRSLEDDIRSDTS |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DJD0 | S1466 | Sugiyama | RGPD1 RANBP2L6 RGP1 | DEAKTAQEKDsLItPHVsRsstPREsPCGKIAVAVLEEtTR |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10809 | S398 | Sugiyama | HSPD1 HSP60 | LDVttsEyEKEKLNERLAKLsDGVAVLKVGGtsDVEVNEKK |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | T422 | Sugiyama | HSPD1 HSP60 | AVLKVGGtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGC |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | T332 | Sugiyama | LAMC1 LAMB2 | YGVDCEKCLPFFNDRPWRRAtAEsASECLPCDCNGRsQECy |
| P11047 | Y860 | Sugiyama | LAMC1 LAMB2 | GNCNRLTGECLKCIyNtAGFyCDRCKDGFFGNPLAPNPADK |
| P11142 | S340 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | ALRDAKLDKsQIHDIVLVGGstRIPKIQKLLQDFFNGKELN |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11413 | S106 | Sugiyama | G6PD | PFFKATPEEKLKLEDFFARNsyVAGQyDDAAsyQRLNsHMN |
| P11586 | S490 | Sugiyama | MTHFD1 MTHFC MTHFD | QTDKALFNRLVPSVNGVRRFsDIQIRRLKRLGIEKTDPTTL |
| P11586 | S870 | Sugiyama | MTHFD1 MTHFC MTHFD | EVYTKQGFGNLPICMAKtHLsLsHNPEQKGVPTGFILPIRD |
| P11586 | T867 | Sugiyama | MTHFD1 MTHFC MTHFD | HKAEVYTKQGFGNLPICMAKtHLsLsHNPEQKGVPTGFILP |
| P11940 | S51 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | FSPAGPILsIRVCRDMITRRsLGyAyVNFQQPADAERALDt |
| P11940 | S96 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | VIKGKPVRIMWSQRDPsLRKsGVGNIFIKNLDKSIDNKALy |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | T322 | Sugiyama | CKB CKBB | LGKHEKFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRL |
| P12277 | T327 | Sugiyama | CKB CKBB | KFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRLGFSEV |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P13010 | S318 | Sugiyama | XRCC5 G22P2 | NDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSEGK |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13804 | S192 | Sugiyama | ETFA | sFDAAATsGGsASsEKAsStsPVEIsEWLDQKLTKSDRPEL |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | T479 | Sugiyama | PRKCSH G19P1 | KFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPSR |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S346 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | CAtQMLEsMIKKPRPTRAEGsDVANAVLDGADCIMLSGEtA |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14866 | S471 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | VCVSKQPAIMPGQSyGLEDGsCsyKDFSESRNNRFstPEQA |
| P14866 | S539 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | EICDELGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETL |
| P14866 | S542 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | DELGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFL |
| P14866 | S543 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | ELGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLN |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P14868 | S190 | Sugiyama | DARS1 DARS PIG40 | GRATVNQDTRLDNRVIDLRTsTsQAVFRLQSGICHLFRETL |
| P15328 | S149 | Sugiyama | FOLR1 FOLR | VLNVPLCKEDCEQWWEDCRTsYTCKSNWHKGWNWTSGFNKC |
| P15924 | S1658 | Sugiyama | DSP | DVLDGHLREKQRTQEELRRLssEVEALRRQLLQEQESVKQA |
| P16070 | S43 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLNITCRFAGVFHVEKNGRYsIsRtEAADLCKAFNSTLPTM |
| P16083 | S83 | Sugiyama | NQO2 NMOR2 | PEVFNyGVEtHEAyKQRsLAsDITDEQKKVREADLVIFQFP |
| P16930 | S165 | Sugiyama | FAH | ENALMPNWLHLPVGYHGRAssVVVSGTPIRRPMGQMKPDDS |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17174 | S106 | Sugiyama | GOT1 | RLALGDDsPALKEKRVGGVQsLGGtGALRIGADFLARWYNG |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P17987 | S374 | Sugiyama | TCP1 CCT1 CCTA | ERICDDELILIKNTKARTsAsIILRGANDFMCDEMERSLHD |
| P18615 | S131 | Sugiyama | NELFE RD RDBP | QRsIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S118 | Sugiyama | PGAM1 PGAMA CDABP0006 | LNKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsK |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19174 | S1233 | Sugiyama | PLCG1 PLC1 | PAKENGDLsPFsGtsLRERGsDASGQLFHGRAREGsFEsRy |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20618 | S162 | Sugiyama | PSMB1 PSC5 | DEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLDNQVG |
| P22059 | S379 | Sugiyama | OSBP OSBP1 | FFDAPEIITMPENLGHKRtGsNIsGAssDIsLDEQyKHQLE |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | S231 | Sugiyama | HNRNPA2B1 HNRPA2B1 | DsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyNGyGGGP |
| P23142 | S247 | Sugiyama | FBLN1 PP213 | CRLGESCINTVGSFRCQRDssCGtGYELTEDNSCKDIDECE |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25705 | S76 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | EERILGADtsVDLEETGRVLsIGDGIARVHGLRNVQAEEMV |
| P25786 | S211 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | GLRALRETLPAEQDLttKNVsIGIVGKDLEFTIyDDDDVsP |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25963 | S262 | PSP | NFKBIA IKBA MAD3 NFKBI | DVNRVTYQGYSPYQLTWGRPsTRIQQQLGQLTLENLQMLPE |
| P25963 | S32 | EPSD|PSP | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P25963 | S63 | PSP | NFKBIA IKBA MAD3 NFKBI | EQMVKELQEIRLEPQEVPRGsEPWKQQLTEDGDSFLHLAII |
| P26232 | T657 | Sugiyama | CTNNA2 CAPR | EDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26639 | S702 | Sugiyama | TARS1 TARS | ISGTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAEEE |
| P26639 | T704 | Sugiyama | TARS1 TARS | GTVNIRTRDNKVHGERtIsEtIERLQQLKEFRSKQAEEEF_ |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S145 | Sugiyama | YWHAQ | YFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHP |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | T141 | Sugiyama | YWHAQ | MKGDYFRyLAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQ |
| P27694 | S384 | Sugiyama | RPA1 REPA1 RPA70 | DADKFDGSRQPVLAIKGARVsDFGGRsLsVLSsSTIIANPD |
| P27695 | S129 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | QELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDE |
| P27708 | S133 | Sugiyama | CAD | IPGLQGVDTRELTKKLREQGsLLGKLVQNGTEPSSLPFLDP |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P28066 | S172 | Sugiyama | PSMA5 | QLFHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLK |
| P28066 | S174 | Sugiyama | PSMA5 | FHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEA |
| P29401 | S190 | Sugiyama | TKT | ASIYKLDNLVAILDINRLGQsDPAPLQHQMDIyQKRCEAFG |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29401 | S473 | Sugiyama | TKT | AtEKAVELAANTKGICFIRTsRPENAIIyNNNEDFQVGQAK |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S70 | Sugiyama | EEF1D EF1D | IARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVE |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30153 | S146 | Sugiyama | PPP2R1A | AHFVPLVKRLAGGDWFTSRTsACGLFSVCYPRVSSAVKAEL |
| P30154 | S158 | Sugiyama | PPP2R1B | AYFVPLVKRLASGDWFTSRTsACGLFSVCYPRASNAVKAEI |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P31150 | S213 | Sugiyama | GDI1 GDIL OPHN2 RABGDIA XAP4 | RTDDyLDQPCLETVNRIKLYsEsLARYGKsPYLyPLyGLGE |
| P31327 | S898 | Sugiyama | CPS1 | LYKMRDILNMEKTLKGLNsEsMtEEtLKRAKEIGFSDKQIS |
| P31939 | S554 | Sugiyama | ATIC PURH OK/SW-cl.86 | VSISSDAFFPFRDNVDRAKRsGVAyIAAPSGsAADKVVIEA |
| P31943 | S54 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | CKIQNGAQGIRFIYTREGRPsGEAFVELEsEDEVKLALKKD |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32969 | S182 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | QQATTVKNKDIRKFLDGIyVsEKGtVQQADE__________ |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33993 | S409 | Sugiyama | MCM7 CDC47 MCM2 | QLLsyIDRLAPRSQYTTGRGssGVGLTAAVLRDSVSGELTL |
| P33993 | S410 | Sugiyama | MCM7 CDC47 MCM2 | LLsyIDRLAPRSQYTTGRGssGVGLTAAVLRDSVSGELTLE |
| P33993 | S483 | Sugiyama | MCM7 CDC47 MCM2 | EQQTISIAKAGILTTLNARCsILAAANPAyGRYNPRRsLEQ |
| P33993 | S678 | Sugiyama | MCM7 CDC47 MCM2 | ADVIFATVRELVSGGRSVRFsEAEQRCVSRGFTPAQFQAAL |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | S647 | Sugiyama | HSPA4 APG2 HSPH2 | EMRDKLSGEYEKFVSEDDRNsFtLKLEDTENWLyEDGEDQP |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35221 | T658 | Sugiyama | CTNNA1 | LDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P35658 | S421 | Sugiyama | NUP214 CAIN CAN KIAA0023 | FYMINQNPGVKSLIKTPERLsLEGERQPKsPGstPTTPTSS |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38606 | S384 | Sugiyama | ATP6V1A ATP6A1 ATP6V1A1 VPP2 | RLAEMPADSGYPAyLGARLAsFYERAGRVKCLGNPEREGSV |
| P38646 | S148 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | YDDPEVQKDIKNVPFKIVRAsNGDAWVEAHGKLYSPSQIGA |
| P38646 | S212 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | tVPAyFNDsQRQAtKDAGQIsGLNVLRVINEPTAAALAyGL |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40227 | T147 | Sugiyama | CCT6A CCT6 CCTZ | KEKALQFLEEVKVSREMDREtLIDVARTSLRTKVHAELADV |
| P41091 | S107 | Sugiyama | EIF2S3 EIF2G | KIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLV |
| P41223 | T111 | Sugiyama | BUD31 EDG2 | KWKKQGYENLCCLRCIQTRDtNFGtNCICRVPKSKLEVGRI |
| P41567 | T46 | Sugiyama | EIF1 SUI1 | GTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKKK |
| P42566 | S368 | Sugiyama | EPS15 AF1P | EKNNVEQDLKEKEDTIKQRtsEVQDLQDEVQRENTNLQKLQ |
| P42677 | T74 | Sugiyama | RPS27 MPS1 | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| P43121 | S93 | Sugiyama | MCAM MUC18 | IFRVRQGQGQSEPGEYEQRLsLQDRGAtLALtQVtPQDERI |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43243 | S211 | Sugiyama | MATR3 KIAA0723 | DRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCR |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P45974 | S783 | Sugiyama | USP5 ISOT | IDDLDAEAAMDISEGRsAADsIsEsVPVGPKVRDGPGKYQL |
| P45974 | Y853 | Sugiyama | USP5 ISOT | NDQKVCASEKPPKDLGyIyFyQRVAS_______________ |
| P46013 | S648 | Sugiyama | MKI67 | RVSISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLG |
| P46459 | S207 | Sugiyama | NSF | KAENSSLNLIGKAKTKENRQsIINPDWNFEKMGIGGLDKEF |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P47712 | S178 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | RQQRKEHIRESMKKLLGPKNsEGLHSARDVPVVAILGSGGG |
| P47712 | S724 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | NIDVIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFL |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P48637 | S276 | Sugiyama | GSS | VDGQEIAVVYFRDGYMPRQYsLQNWEARLLLERSHAAKCPD |
| P48643 | S51 | Sugiyama | CCT5 CCTE KIAA0098 | LEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtVT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49327 | S1997 | Sugiyama | FASN FAS | DGLLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFV |
| P49327 | S519 | Sugiyama | FASN FAS | MGTQWRGMGLSLMRLDRFRDsILRsDEAVKPFGLKVSQLLL |
| P49589 | S312 | Sugiyama | CARS1 CARS | GDQKALQEGEGDLsIsADRLsEKRSPNDFALWKASKPGEPS |
| P49736 | S187 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | MIEsIENLEDLKGHSVREWVsMAGPRLEIHHRFKNFLRTHV |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P49792 | S2457 | Sugiyama | RANBP2 NUP358 | DEAKTAQEKDsLItPHVsRsstPREsPCGKIAVAVLEEtTR |
| P49792 | T1098 | Sugiyama | RANBP2 NUP358 | GDGYsGAKPIPGGQTIGPRNtFNFGSKNVsGIsFtENMGss |
| P50213 | S207 | Sugiyama | IDH3A | ARNNHRSNVTAVHKANIMRMsDGLFLQKCREVAESCKDIKF |
| P50395 | S213 | Sugiyama | GDI2 RABGDIB | RtDDyLDQPCyEtINRIKLYsEsLARYGKsPYLyPLyGLGE |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | S427 | Sugiyama | GDI2 RABGDIB | ttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED__ |
| P50395 | T425 | Sugiyama | GDI2 RABGDIB | DAttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51153 | S155 | Sugiyama | RAB13 GIG4 | QADKLAREHGIRFFETSAKSsMNVDEAFSsLARDILLKSGG |
| P51570 | S230 | Sugiyama | GALK1 GALK | LVPLSDPKLAVLITNSNVRHsLASSEYPVRRRQCEEVARAL |
| P51617 | S591 | Sugiyama | IRAK1 IRAK | sAQAAEQLQRGPNQPVEsDEsLGGLsAALRsWHLtPsCPLD |
| P51813 | Y360 | Sugiyama | BMX | NDKKGTVKHYHVHTNAENKLyLAENyCFDsIPKLIHyHQHN |
| P51813 | Y365 | Sugiyama | BMX | TVKHYHVHTNAENKLyLAENyCFDsIPKLIHyHQHNsAGMI |
| P51813 | Y90 | Sugiyama | BMX | EQtPVERQyPFQIVyKDGLLyVyASNEESRSQWLKALQKEI |
| P51813 | Y92 | Sugiyama | BMX | tPVERQyPFQIVyKDGLLyVyASNEESRSQWLKALQKEIRG |
| P51858 | S83 | Sugiyama | HDGF HMG1L2 | LFPyEEsKEKFGKPNKRKGFsEGLWEIENNPtVKASGYQSs |
| P51991 | S350 | Sugiyama | HNRNPA3 HNRPA3 | NDFGNYSGQQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGs |
| P51991 | S355 | Sugiyama | HNRNPA3 HNRPA3 | YSGQQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGs |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P52209 | S126 | Sugiyama | PGD PGDH | YRDTTRRCRDLKAKGILFVGsGVsGGEEGARyGPSLMPGGN |
| P52597 | S54 | Sugiyama | HNRNPF HNRPF | CtIHDGAAGVHFIYTREGRQsGEAFVELGsEDDVKMALKKD |
| P52789 | S408 | Sugiyama | HK2 | ATLAAVLQRIKENKGEERLRstIGVDGsVyKKHPHFAKRLH |
| P52789 | T409 | Sugiyama | HK2 | TLAAVLQRIKENKGEERLRstIGVDGsVyKKHPHFAKRLHK |
| P52907 | S123 | Sugiyama | CAPZA1 | KEAsDPQPEEADGGLKsWREsCDsALRAYVKDHYSNGFCTV |
| P53041 | S403 | Sugiyama | PPP5C PPP5 | DLLWSDPQPQNGRSISKRGVsCQFGPDVTKAFLEENNLDyI |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S656 | Sugiyama | ACLY | IGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISR |
| P54578 | S431 | Sugiyama | USP14 TGT | GSNNCGYYDLQAVLTHQGRSssSGHyVSWVKRKQDEWIKFD |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P55084 | S284 | Sugiyama | HADHB MSTP029 | VVPFKVPGKDTVTKDNGIRPsSLEQMAKLKPAFIKPYGTVT |
| P56537 | S6 | Sugiyama | EIF6 EIF3A ITGB4BP OK/SW-cl.27 | _______________MAVRAsFENNCEIGCFAKLTNTYCLV |
| P56937 | S337 | Sugiyama | HSD17B7 17HSD7 SDR37C1 UNQ2563/PRO6243 | LELEKHIRVTIQKTDNQARLsGsCL________________ |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57721 | S158 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | AsQCGsLIGKGGSKIKEIREstGAQVQVAGDMLPNstERAV |
| P57721 | S59 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | EGGLNVTLTIRLLMHGKEVGsIIGKKGETVKKMREESGARI |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P57721 | T159 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | sQCGsLIGKGGSKIKEIREstGAQVQVAGDMLPNstERAVT |
| P57723 | S31 | Sugiyama | PCBP4 | EPELSITLTLRMLMHGKEVGsIIGKKGETVKRIREQSSARI |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60228 | S442 | Sugiyama | EIF3E EIF3S6 INT6 | IEKKLNQNSRSEAPNWAtQDsGFy_________________ |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61163 | S331 | Sugiyama | ACTR1A CTRN1 | GDRLLSEVKKLAPKDVKIRIsAPQERLYSTWIGGSILASLD |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61764 | S469 | Sugiyama | STXBP1 UNC18A | PIVTDSTLRRRSKPERKERIsEQTyQLSRWTPIIKDIMEDT |
| P61764 | S507 | Sugiyama | STXBP1 UNC18A | EDTIEDKLDTKHYPYISTRssAsFSTTAVsARYGHWHKNKA |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | T39 | Sugiyama | HNRNPK HNRPK | FGKRPAEDMEEEQAFKRsRNtDEMVELRILLQSKNAGAVIG |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62753 | S53 | Sugiyama | RPS6 OK/SW-cl.2 | AtEVAADALGEEWKGYVVRIsGGNDKQGFPMKQGVLTHGRV |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63146 | S142 | Sugiyama | UBE2B RAD6B UBCH1 | ANSQAAQLYQENKREYEKRVsAIVEQsWNDS__________ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68431 | S11 | SIGNOR|EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P68431 | S29 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | RKstGGKAPRKQLATKAARKsAPATGGVKKPHRyRPGtVAL |
| P78371 | S470 | Sugiyama | CCT2 99D8.1 CCTB | IADNAGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAI |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P98082 | S723 | Sugiyama | DAB2 DOC2 | DANQLLNKINEPPKPAPRQVsLPVTKstDNAFENPFFKDsF |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q00610 | S1483 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VNEsLNNLFITEEDyQALRTsIDAyDNFDNIsLAQRLEKHE |
| Q00610 | S576 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | YNLIQQCTAFLLDALKNNRPsEGPLQTRLLEMNLMHAPQVA |
| Q00610 | S751 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | YIQAACKTGQIKEVERICREsNCyDPERVKNFLKEAKLTDQ |
| Q01082 | S2074 | Sugiyama | SPTBN1 SPTB2 | KLIKRHEAFEKSAATWDERFsALERLTTLELLEVRRQQEEE |
| Q01082 | S825 | Sugiyama | SPTBN1 SPTB2 | EQASALPQEHAEsPDVRGRLsGIEERYKEVAELTRLRKQAL |
| Q02790 | T278 | Sugiyama | FKBP4 FKBP52 | sWEMNsEEKLEQSTIVKERGtVYFKEGKYKQALLQYKKIVS |
| Q02818 | S369 | Sugiyama | NUCB1 NUC | RFEEELAAREAELNAKAQRLsQETEALGRsQGRLEAQKREL |
| Q04446 | S75 | Sugiyama | GBE1 | ILKNIGENEGGIDKFSRGyEsFGVHRCADGGLYCKEWAPGA |
| Q04637 | S1199 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | TPATKRsFsKEVEERsRERPsQPEGLRKAAsLtEDRDRGRD |
| Q04695 | S28 | Sugiyama | KRT17 | FTSSSsIKGSSGLGGGsSRTsCRLsGGLGAGsCRLGSAGGL |
| Q04695 | S32 | Sugiyama | KRT17 | SsIKGSSGLGGGsSRTsCRLsGGLGAGsCRLGSAGGLGSTL |
| Q04726 | S196 | Sugiyama | TLE3 KIAA1547 | AHLTVKDEKNHHELDHREREssANNsVsPsEsLRAsEKHRG |
| Q04726 | S197 | Sugiyama | TLE3 KIAA1547 | HLTVKDEKNHHELDHREREssANNsVsPsEsLRAsEKHRGs |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06210 | T263 | Sugiyama | GFPT1 GFAT GFPT | QGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDASA |
| Q06830 | S32 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | APNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVC |
| Q07021 | S106 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | LsDEIKEERKIQKHKTLPKMsGGWELELNGTEAKLVRKVAG |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q08211 | S449 | Sugiyama | DHX9 DDX9 LKP NDH2 | FIQNDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSC |
| Q08211 | S452 | Sugiyama | DHX9 DDX9 LKP NDH2 | NDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSCGYS |
| Q08211 | S623 | Sugiyama | DHX9 DDX9 LKP NDH2 | DDDANCNLICGDEyGPETRLsMsQLNEKETPFELIEALLKY |
| Q08378 | S465 | Sugiyama | GOLGA3 | LSTKLQAQVECSHSSQQRQDsLsSEVDTLKQsCWDLERAMT |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q13085 | S1762 | Sugiyama | ACACA ACAC ACC1 ACCA | EDPYKGYRYLYLTPQDYKRVsALNsVHCEHVEDEGESRYKI |
| Q13098 | S240 | Sugiyama | GPS1 COPS1 CSN1 | SYVSKAESTPEIAEQRGERDsQtQAILTKLKCAAGLAELAA |
| Q13098 | T242 | Sugiyama | GPS1 COPS1 CSN1 | VSKAESTPEIAEQRGERDsQtQAILTKLKCAAGLAELAARK |
| Q13162 | S68 | Sugiyama | PRDX4 | EEECHFyAGGQVyPGEAsRVsVADHsLHLSKAKISKPAPYW |
| Q13263 | S479 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERLDLDLtA |
| Q13263 | T415 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LNAWTKSAEAFGKIVAERPGtNstGPAPMAPPRAPGPLSKQ |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13310 | S51 | Sugiyama | PABPC4 APP1 PABP4 | FSPAGPVLsIRVCRDMITRRsLGyAyVNFQQPADAERALDt |
| Q13310 | S96 | Sugiyama | PABPC4 APP1 PABP4 | VIKGKPIRIMWSQRDPsLRKsGVGNVFIKNLDKSIDNKALy |
| Q13501 | S24 | Sugiyama | SQSTM1 ORCA OSIL | LTVKAYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPC |
| Q13547 | S434 | Sugiyama | HDAC1 RPD3L1 | IACEEEFsDsEEEGEGGRKNsSNFKKAKRVKTEDEKEKDPE |
| Q13610 | S484 | Sugiyama | PWP1 | SSVNEAFGRRERLVLGSARNssISGPFGsRssDTPMES___ |
| Q13610 | S485 | Sugiyama | PWP1 | SVNEAFGRRERLVLGSARNssISGPFGsRssDTPMES____ |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S1262 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRERDDRRD |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S895 | Sugiyama | EIF3A EIF3S10 KIAA0139 | ERRLGDssLSRKDSRWGDRDsEGtWRKGPEADsEWRRGPPE |
| Q14157 | S852 | Sugiyama | UBAP2L KIAA0144 NICE4 | LDyysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASS |
| Q14204 | T1255 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | QVANLQMKIVQEDRAVESRTtDLLTDWEKTKPVTGNLRPEE |
| Q14498 | S333 | Sugiyama | RBM39 HCC1 RNPC2 | GFELAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGt |
| Q14566 | S271 | Sugiyama | MCM6 | VPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRD |
| Q14566 | S498 | Sugiyama | MCM6 | EQQTISITKAGVKATLNARTsILAAANPIsGHyDRSKSLKQ |
| Q14568 | S164 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | VAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGT |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | T171 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | ITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTKVILHLK |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14669 | S1054 | Sugiyama | TRIP12 KIAA0045 ULF | TQsPKSSFLASLNPKTWGRLstQsNSNNIEPARTAGGSGLA |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14677 | Y172 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | AKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDEEWDKNK |
| Q14697 | S190 | Sugiyama | GANAB G2AN KIAA0088 | VNARGLLEFEHQRAPRVsQGsKDPAEGDGAQPEEtPRDGDK |
| Q15021 | S585 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | ILGLIFKGPAASTQEKNPREstGNMVTGQTVCKNKPNMsDP |
| Q15021 | T586 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | LGLIFKGPAASTQEKNPREstGNMVTGQTVCKNKPNMsDPE |
| Q15084 | S156 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | KDRLGGRSGGYSSGKQGRSDsSSKKDVIELtDDsFDKNVLD |
| Q15084 | S389 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | FALLKGsFsEQGINEFLRELsFGRGstAPVGGGAFPtIVER |
| Q15084 | S394 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | GsFsEQGINEFLRELsFGRGstAPVGGGAFPtIVEREPWDG |
| Q15084 | S88 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AATALKDVVKVGAVDADKHHsLGGQyGVQGFPtIKIFGSNK |
| Q15084 | T395 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | sFsEQGINEFLRELsFGRGstAPVGGGAFPtIVEREPWDGR |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15185 | S85 | Sugiyama | PTGES3 P23 TEBP | KHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVDFNN |
| Q15365 | S126 | Sugiyama | PCBP1 | ATQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAI |
| Q15365 | S27 | Sugiyama | PCBP1 | ESGLNVTLTIRLLMHGKEVGsIIGKKGESVKRIREEsGARI |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15365 | T127 | Sugiyama | PCBP1 | TQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15366 | S126 | Sugiyama | PCBP2 | AsQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAI |
| Q15366 | S27 | Sugiyama | PCBP2 | EGGLNVTLTIRLLMHGKEVGsIIGKKGESVKKMREESGARI |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15366 | T127 | Sugiyama | PCBP2 | sQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16658 | S120 | Sugiyama | FSCN1 FAN1 HSN SNL | RWSLQSEAHRRYFGGtEDRLsCFAQtVsPAEKWSVHIAMHP |
| Q4VXU2 | S96 | Sugiyama | PABPC1L C20orf119 | MLKGQPIRIMWSQRDPGLRKsGVGNIFIKNLEDSIDNKALY |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q5JQF8 | S87 | Sugiyama | PABPC1L2A PABPC1L2 RBM32A; PABPC1L2B PABPC1L2 RBM32B | VIKGRPVRIMWSQRDPsLRKsGVGNVFIKNLGKTIDNKALY |
| Q5JTD0 | S545 | Sugiyama | TJAP1 PILT TJP4 | ssRPQRsPKRMGVHHLHRKDsLtQAQEQGNLLN________ |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5T4S7 | S1752 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | PssGMsSTMKESAFQsEPRIsESLVRHAstssPADKAKVTI |
| Q5T4S7 | S3846 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | KELLEYDLQQREAATKSSRTsVQPTFTASQyRALsVLGCGH |
| Q5T5C0 | S692 | Sugiyama | STXBP5 LLGL3 | YGSNDPYRREPRSPRKsRQPsGAGLCDIsEGtVVPEDRCKS |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q6GYQ0 | S864 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | AERLRSGNASTMTRRGssPGsLEIPKDLPDILNKQNQMRPI |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PIW4 | S616 | Sugiyama | FIGNL1 | IVQQSDAFSGADMTQLCREAsLGPIRSLQTADIATITPDQV |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UVK1 | S321 | Sugiyama | CSPG4 MCSP | DQYPTHTSNRGVLSYLEPRGsLLLGGLDAEASRHLQEHRLG |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71UM5 | T74 | Sugiyama | RPS27L | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7Z3J3 | S1482 | Sugiyama | RGPD4 RGP4 | DEAKTAQEKDsLItPHVsRsstPREsPCGKIAVAVLEEtTR |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z460 | S253 | Sugiyama | CLASP1 KIAA0622 MAST1 | IQSANDKNFDDEDsVDGNRPssAsStSSKAPPSSRRNVGMG |
| Q7Z5L9 | S457 | Sugiyama | IRF2BP2 | GSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVGGQ |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8IZ83 | S427 | Sugiyama | ALDH16A1 | SPFRTAKEALLVANGtPRGGsASVWSERLGQALELGYGLQV |
| Q8IZ83 | S550 | Sugiyama | ALDH16A1 | LFVGGRFQAPGARSSRPIRDssGNLHGYVAEGGAKDIRGAV |
| Q8N0Y7 | S118 | Sugiyama | PGAM4 PGAM3 | LNKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsK |
| Q8N6H7 | S123 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | NTKYNSRAAQMYREKIRQLGsAALARHGTDLWIDNMssAVP |
| Q8NBJ5 | S607 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | DRAKSQKMREQQALSREAKNsDVLQsPLDsAARDEL_____ |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBP7 | S595 | Sugiyama | PCSK9 NARC1 PSEC0052 | KPPVLRPRGQPNQCVGHREAsIHASCCHAPGLECKVKEHGI |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q8NHP8 | S201 | Sugiyama | PLBD2 | QVRLTLLQLKGLEDSYEGRVsFPAGKFTIKPLGFLLLQLSG |
| Q8TCS8 | S768 | Sugiyama | PNPT1 PNPASE | SRKVLQsPAtTVVRTLNDRssIVMGEPIsQSSSNsQ_____ |
| Q8TD19 | S332 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | RREMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVW |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8TEW0 | S962 | Sugiyama | PARD3 PAR3 PAR3A | DEGMEtLEEDTEESSRsGREsVstAsDQPsHsLERQMNGNQ |
| Q8WW59 | S113 | Sugiyama | SPRYD4 | TVKRSQQFRIGVADVDMSRDsCIGVDDRSWVFTYAQRKWYT |
| Q8WWM7 | S273 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | PNEMFKFNEENyGVKTtyDssLssytVPLEKDNsEEFRQRE |
| Q8WWM7 | S500 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | VTSSVSDPGVGsIsPAsPKIsLAPTDVKELSTKEPGRTLEP |
| Q8WX93 | S1352 | Sugiyama | PALLD KIAA0992 CGI-151 | QsQstKPKKVRPSASRyAALsDQGLDIKAAFQPEANPSHLT |
| Q92547 | S998 | Sugiyama | TOPBP1 KIAA0259 | AQECKHLPESLYPHTYNPKMsLDIsAVQDGRLCNSRLLSAV |
| Q92597 | S332 | Sugiyama | NDRG1 CAP43 DRG1 RTP | MGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGTRs |
| Q92609 | S732 | Sugiyama | TBC1D5 KIAA0210 | sDDFILISKDDDGssARGsFsGQAQPLRtLRSTSGKSQAPV |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q969S3 | S38 | Sugiyama | ZNF622 ZPR9 | MQRAHYKTDWHRYNLRRKVAsMAPVTAEGFQERVRAQRAVA |
| Q96D15 | S117 | Sugiyama | RCN3 UNQ239/PRO272 | VsLAELRAWIAHTQQRHIRDsVsAAWDtyDtDRDGRVGWEE |
| Q96D46 | S462 | Sugiyama | NMD3 CGI-07 | FLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAE |
| Q96DU9 | S103 | Sugiyama | PABPC5 PABP5 | LINGKPFRLMWSQPDDRLRKsGVGNIFIKNLDKSIDNRALF |
| Q96G46 | T240 | Sugiyama | DUS3L | KREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPRQENC |
| Q96GD4 | Y92 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | FtIDDFEIGRPLGKGKFGNVyLAREKKSHFIVALKVLFKSQ |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96K76 | S917 | Sugiyama | USP47 | sKstEtsDFENIEsPLNERDsSAsVDNRELEQHIQtsDPEN |
| Q96RS6 | S373 | Sugiyama | NUDCD1 CML66 | EGLTWPELVIGDKQGELIRDsAQCAAIAERLMHLtsEELNP |
| Q99584 | S32 | Sugiyama | S100A13 | SIETVVTTFFTFARQEGRKDsLsVNEFKELVTQQLPHLLKD |
| Q99666 | S1481 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | DEAKTAQEKDsLItPHVsRsstPREsPCGKIAVAILEETTR |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9C0C2 | S1383 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | REHGVGGVsQCPEPGLRHNGsLsPGLEARDPLEARELGVGE |
| Q9C0C2 | S1533 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GEAsQTEDVDGTWGSSAARWsDQGPAQTSRRPsQGPPARsP |
| Q9C0C2 | S1616 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | LSEAADsDAHLFQDSTEPRAsRVPssDEEVVEEPQsRRTRM |
| Q9C0C2 | S936 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GRyssQDADEQDWEFQKRDVsLGTyGSRAAEPQEQEFGKSA |
| Q9C0C2 | S962 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | SRAAEPQEQEFGKSAWIRDyssGGsSRtLDAQDRsFGtRPL |
| Q9H0B6 | S428 | Sugiyama | KLC2 | NKPIWMHAEEREESKDKRRDsAPyGEyGsWYKACKVDsPtV |
| Q9H0D6 | S678 | Sugiyama | XRN2 | LRAALEEVyPDLTPEEtRRNsLGGDVLFVGKHHPLHDFILE |
| Q9H2G2 | S340 | Sugiyama | SLK KIAA0204 STK2 | EEDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACIL |
| Q9H3N1 | S270 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | EAEsKEGtNKDFPQNAIRQRsLGPsLAtDKs__________ |
| Q9H3Q1 | S309 | Sugiyama | CDC42EP4 BORG4 CEP4 | AAPsPGsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPD |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H814 | S149 | Sugiyama | PHAX RNUXA | AVATELGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTK |
| Q9HA65 | S366 | Sugiyama | TBC1D17 | EYFRMKLQWKSVSPEQERRNsLLHGYRSLIERDVSRTDRTN |
| Q9NQS7 | S893 | EPSD|PSP | INCENP | LPLDLEDIFKKSKPRYHKRtssAVWNsPPLQGARVPssLAY |
| Q9NQS7 | S894 | EPSD|PSP | INCENP | PLDLEDIFKKSKPRYHKRtssAVWNsPPLQGARVPssLAYs |
| Q9NQS7 | T892 | EPSD|PSP | INCENP | ILPLDLEDIFKKSKPRYHKRtssAVWNsPPLQGARVPssLA |
| Q9NQX3 | S262 | Sugiyama | GPHN GPH KIAA1385 | AKIPDSIISRGVQVLPRDTAsLsttPsEsPRAQAtsRLstA |
| Q9NQX3 | S280 | Sugiyama | GPHN GPH KIAA1385 | TAsLsttPsEsPRAQAtsRLstAsCPtPKVQSRCSsKENIL |
| Q9NR45 | S253 | Sugiyama | NANS SAS | KVLERHITLDKTWKGsDHsAsLEPGELAELVRSVRLVERAL |
| Q9NRA8 | S353 | Sugiyama | EIF4ENIF1 | SASRFSRWFSNPsRsGsRsssLGstPHEELERLAGLEQAIL |
| Q9NRX4 | S80 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | VSGDMQKQGCDCECLGGGRIsHQSQDKKIHVyGysMAyGPA |
| Q9NXH9 | S514 | Sugiyama | TRMT1 | ALWDIMRCWEKECPVKRERLsETsPAFRILsVEPRLQANFT |
| Q9NZB2 | S30 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | IEKHCPsAVVPVELQKLARGsLVGGGRQRPPQTPLRLLVDA |
| Q9NZL9 | S9 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | ____________MVGREKELsIHFVPGsCRLVEEEVNIPNR |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9UBC2 | S374 | Sugiyama | EPS15L1 EPS15R | LsPDMVPPsERGtPGPDssGsLGsGEFTGVKELDDISQEIA |
| Q9UBR2 | S78 | Sugiyama | CTSZ | SPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHAST |
| Q9UBU9 | S431 | Sugiyama | NXF1 TAP | HDGACCSLSIPFIPQNPARSsLAEyFKDSRNVKKLKDPTLR |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | S334 | Sugiyama | NDRG3 | GYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDG |
| Q9UGV2 | S335 | Sugiyama | NDRG3 | YIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGt |
| Q9UHD1 | S200 | Sugiyama | CHORDC1 CHP1 | SGVPIFHEGMKYWSCCRRKtsDFNtFLAQEGCtKGKHMWTK |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9ULD2 | S1224 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | tEQAVLQESLEKESKVNKRLsMENEELLWKLHNGDLCsPKR |
| Q9ULD2 | S1259 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | LCsPKRsPtssAIPLQsPRNsGsFPsPsIsPR_________ |
| Q9ULT8 | S1571 | Sugiyama | HECTD1 KIAA1131 | RVANIARTNAtNNMNLsRsssDNNTNtLGRNVMSTATSPLM |
| Q9ULX3 | S390 | Sugiyama | NOB1 ART4 NOB1P PSMD8BP1 MSTP158 | VsPFVENDISSRSATLQVRDsTLGAGRRRLNPNASRKKFVK |
| Q9UNH7 | S55 | Sugiyama | SNX6 | DISDALSERDKVKFTVHTKSsLPNFKQNEFSVVRQHEEFIW |
| Q9UNN5 | S518 | Sugiyama | FAF1 UBXD12 UBXN3A CGI-03 | EDEREARENVKREQDEAyRLsLEADRAKREAHEREMAEQFR |
| Q9UNZ2 | T73 | Sugiyama | NSFL1C UBXN2C | ISQATPssVsRGTAPSDNRVtsFRDLIHDQDEDEEEEEGQR |
| Q9UPQ0 | S190 | Sugiyama | LIMCH1 KIAA1102 | PKRSIRDsGyIDCWDsERsDsLsPPRHGRDDsFDsLDsFGs |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UPQ0 | S207 | Sugiyama | LIMCH1 KIAA1102 | RsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVVLRGssD |
| Q9UPQ0 | Y179 | Sugiyama | LIMCH1 KIAA1102 | QMRKDTDDIEsPKRSIRDsGyIDCWDsERsDsLsPPRHGRD |
| Q9UPU5 | S1685 | Sugiyama | USP24 KIAA1057 | QPDPALTKEFDYLPPVDSRSssGFVGLRNGGATCYMNAVFQ |
| Q9UPU5 | S1686 | Sugiyama | USP24 KIAA1057 | PDPALTKEFDYLPPVDSRSssGFVGLRNGGATCYMNAVFQQ |
| Q9UPU5 | S88 | Sugiyama | USP24 KIAA1057 | GGPRGDGGGDGGGGGPsRGGstGGGGGFDPPPAYHEVVDAE |
| Q9UQB9 | Y58 | Sugiyama | AURKC AIE2 AIK3 AIRK3 ARK3 STK13 | LTVDDFEIGRPLGKGKFGNVyLARLKESHFIVALKVLFKSQ |
| Q9Y230 | S43 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | GAHSHIRGLGLDDALEPRQAsQGMVGQLAARRAAGVVLEMI |
| Q9Y262 | S80 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | HKTVSDLIDQKVYELQASRVssDVIDQKVyEIQDIyENSWT |
| Q9Y262 | S81 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | KTVSDLIDQKVYELQASRVssDVIDQKVyEIQDIyENSWTK |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
| Q9Y2U5 | S239 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | SLDSPLDGESYPKSRMPRAQsyPDNHQEFSDyDNPIFEKFG |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y696 | S31 | Sugiyama | CLIC4 | KEEDKEPLIELFVKAGsDGEsIGNCPFSQRLFMILWLKGVV |
| Q9Y6E0 | S434 | Sugiyama | STK24 MST3 STK3 | ACPGISDTMVAQLVQRLQRYsLSGGGtSsH___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin modifying enzymes | R-HSA-3247509 | 2.473321e-07 | 6.607 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.502664e-07 | 6.259 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.184070e-07 | 6.144 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.084057e-07 | 6.042 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.741035e-06 | 5.759 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.826211e-06 | 5.549 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.446855e-05 | 4.611 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.354599e-05 | 4.271 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.125074e-05 | 4.213 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.579131e-05 | 4.182 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.059009e-05 | 4.151 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.652351e-05 | 4.116 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.203690e-04 | 3.919 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.483695e-04 | 3.829 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.750428e-04 | 3.757 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.768750e-04 | 3.752 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.773269e-04 | 3.751 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.963692e-04 | 3.707 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.415908e-04 | 3.466 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.456479e-04 | 3.461 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.397695e-04 | 3.357 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.637781e-04 | 3.334 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.988401e-04 | 3.302 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.681559e-04 | 3.246 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.813101e-04 | 3.167 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.343040e-04 | 3.079 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.119705e-03 | 2.951 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.217574e-03 | 2.915 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.217574e-03 | 2.915 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.238275e-03 | 2.907 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.292913e-03 | 2.888 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.315392e-03 | 2.881 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.322526e-03 | 2.879 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.457319e-03 | 2.836 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.105868e-03 | 2.677 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.141392e-03 | 2.669 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.250847e-03 | 2.648 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.469167e-03 | 2.607 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.583019e-03 | 2.588 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.748479e-03 | 2.561 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.864670e-03 | 2.543 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.705270e-03 | 2.431 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.829938e-03 | 2.417 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.313185e-03 | 2.365 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.911385e-03 | 2.309 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.229184e-03 | 2.282 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.111265e-03 | 2.214 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.206623e-03 | 2.207 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.259835e-03 | 2.203 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.383638e-03 | 2.132 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.398816e-03 | 2.131 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.398816e-03 | 2.131 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.360434e-03 | 2.078 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.971186e-03 | 2.047 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.971186e-03 | 2.047 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.971186e-03 | 2.047 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.728116e-03 | 2.059 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.971186e-03 | 2.047 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 9.940008e-03 | 2.003 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 9.940008e-03 | 2.003 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 9.940008e-03 | 2.003 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 9.940008e-03 | 2.003 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 9.940008e-03 | 2.003 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.611099e-03 | 2.017 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.020859e-02 | 1.991 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.038277e-02 | 1.984 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.095768e-02 | 1.960 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.132398e-02 | 1.946 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.169865e-02 | 1.932 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.207859e-02 | 1.918 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.304726e-02 | 1.884 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.305424e-02 | 1.884 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.319563e-02 | 1.880 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.451312e-02 | 1.838 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.399878e-02 | 1.854 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.522284e-02 | 1.818 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.601264e-02 | 1.796 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.637327e-02 | 1.786 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.627158e-02 | 1.789 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.654652e-02 | 1.781 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.675292e-02 | 1.776 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.677755e-02 | 1.775 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.856077e-02 | 1.731 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.813249e-02 | 1.742 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.146235e-02 | 1.668 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.146235e-02 | 1.668 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.146235e-02 | 1.668 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.146235e-02 | 1.668 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.146235e-02 | 1.668 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.118328e-02 | 1.674 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.965420e-02 | 1.707 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.113609e-02 | 1.675 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.041739e-02 | 1.690 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.075555e-02 | 1.683 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.895446e-02 | 1.722 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.919597e-02 | 1.717 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.936384e-02 | 1.713 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.996697e-02 | 1.700 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.148157e-02 | 1.668 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.156286e-02 | 1.666 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.156286e-02 | 1.666 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.156286e-02 | 1.666 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.156286e-02 | 1.666 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.156286e-02 | 1.666 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.383750e-02 | 1.623 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.383750e-02 | 1.623 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.313909e-02 | 1.636 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.407776e-02 | 1.618 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.468679e-02 | 1.608 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.484335e-02 | 1.605 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.684371e-02 | 1.571 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.684371e-02 | 1.571 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.500899e-02 | 1.602 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.500899e-02 | 1.602 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.500899e-02 | 1.602 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.631131e-02 | 1.580 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.786192e-02 | 1.555 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.786192e-02 | 1.555 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.840515e-02 | 1.547 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.851378e-02 | 1.545 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.916689e-02 | 1.535 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.916689e-02 | 1.535 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.047253e-02 | 1.516 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.047253e-02 | 1.516 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.198805e-02 | 1.495 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.217724e-02 | 1.492 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.274583e-02 | 1.485 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.395688e-02 | 1.469 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.418740e-02 | 1.466 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.464555e-02 | 1.460 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.521935e-02 | 1.453 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.521935e-02 | 1.453 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.525777e-02 | 1.453 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.609051e-02 | 1.443 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.609051e-02 | 1.443 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.609051e-02 | 1.443 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.953600e-02 | 1.403 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.919958e-02 | 1.407 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.135734e-02 | 1.383 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.191702e-02 | 1.378 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.216839e-02 | 1.375 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.237752e-02 | 1.373 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.351296e-02 | 1.361 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.367099e-02 | 1.360 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.367099e-02 | 1.360 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.465421e-02 | 1.350 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 4.491204e-02 | 1.348 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.695703e-02 | 1.328 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.586636e-02 | 1.339 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.941920e-02 | 1.306 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.519464e-02 | 1.345 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.546421e-02 | 1.342 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.658751e-02 | 1.332 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.087150e-02 | 1.294 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.171280e-02 | 1.286 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.226158e-02 | 1.282 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.323787e-02 | 1.274 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.330526e-02 | 1.273 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.341933e-02 | 1.272 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.456610e-02 | 1.263 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.154297e-02 | 1.211 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.786701e-02 | 1.238 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.944004e-02 | 1.226 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.288000e-02 | 1.201 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.195612e-02 | 1.208 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.955098e-02 | 1.225 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.234986e-02 | 1.205 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.755816e-02 | 1.240 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.944004e-02 | 1.226 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.187744e-02 | 1.208 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.392654e-02 | 1.194 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.425326e-02 | 1.192 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.906173e-02 | 1.161 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 7.431118e-02 | 1.129 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 7.431118e-02 | 1.129 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 7.431118e-02 | 1.129 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.665582e-02 | 1.115 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.507010e-02 | 1.125 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.910902e-02 | 1.102 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.788390e-02 | 1.109 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.050255e-02 | 1.152 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.106708e-02 | 1.148 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.054540e-02 | 1.152 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.771952e-02 | 1.109 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.448661e-02 | 1.128 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.448661e-02 | 1.128 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.719321e-02 | 1.112 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 7.665582e-02 | 1.115 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.761171e-02 | 1.110 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.277812e-02 | 1.138 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.055403e-01 | 0.977 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.055403e-01 | 0.977 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.055403e-01 | 0.977 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.055403e-01 | 0.977 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.055403e-01 | 0.977 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.055403e-01 | 0.977 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.055403e-01 | 0.977 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.055403e-01 | 0.977 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.055403e-01 | 0.977 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.055403e-01 | 0.977 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.055403e-01 | 0.977 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.055403e-01 | 0.977 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.055403e-01 | 0.977 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.055403e-01 | 0.977 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.055403e-01 | 0.977 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.055403e-01 | 0.977 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.055403e-01 | 0.977 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.055403e-01 | 0.977 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.055403e-01 | 0.977 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.999475e-01 | 0.699 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.999475e-01 | 0.699 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.999475e-01 | 0.699 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.999475e-01 | 0.699 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.999475e-01 | 0.699 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.999475e-01 | 0.699 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.999475e-01 | 0.699 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.081441e-01 | 0.966 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.451486e-01 | 0.838 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.843952e-01 | 0.546 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 2.843952e-01 | 0.546 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.843952e-01 | 0.546 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 2.843952e-01 | 0.546 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.843952e-01 | 0.546 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.843952e-01 | 0.546 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.843952e-01 | 0.546 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 2.843952e-01 | 0.546 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 2.843952e-01 | 0.546 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.843952e-01 | 0.546 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.843952e-01 | 0.546 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.843952e-01 | 0.546 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 2.843952e-01 | 0.546 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.843952e-01 | 0.546 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 2.843952e-01 | 0.546 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.843952e-01 | 0.546 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.026322e-01 | 0.989 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.026322e-01 | 0.989 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.026322e-01 | 0.989 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.026322e-01 | 0.989 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 1.026322e-01 | 0.989 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.842792e-01 | 0.735 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.842792e-01 | 0.735 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.842792e-01 | 0.735 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.842792e-01 | 0.735 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.263292e-01 | 0.898 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.517584e-01 | 0.819 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.246755e-01 | 0.648 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.246755e-01 | 0.648 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.246755e-01 | 0.648 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.599337e-01 | 0.444 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.599337e-01 | 0.444 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.599337e-01 | 0.444 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.599337e-01 | 0.444 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 3.599337e-01 | 0.444 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.599337e-01 | 0.444 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.599337e-01 | 0.444 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.599337e-01 | 0.444 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.599337e-01 | 0.444 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.599337e-01 | 0.444 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.599337e-01 | 0.444 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.599337e-01 | 0.444 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.599337e-01 | 0.444 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.599337e-01 | 0.444 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.599337e-01 | 0.444 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.599337e-01 | 0.444 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.599337e-01 | 0.444 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.599337e-01 | 0.444 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.599337e-01 | 0.444 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.599337e-01 | 0.444 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 1.245227e-01 | 0.905 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.245227e-01 | 0.905 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.786353e-01 | 0.748 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.441457e-01 | 0.841 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.656351e-01 | 0.576 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.175641e-01 | 0.930 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.066796e-01 | 0.685 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.006493e-01 | 0.997 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.503605e-01 | 0.823 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.866106e-01 | 0.729 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.866106e-01 | 0.729 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.866106e-01 | 0.729 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.356217e-01 | 0.628 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.356217e-01 | 0.628 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.356217e-01 | 0.628 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.356217e-01 | 0.628 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.065893e-01 | 0.513 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.065893e-01 | 0.513 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.065893e-01 | 0.513 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.065893e-01 | 0.513 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 3.065893e-01 | 0.513 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.065893e-01 | 0.513 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.275024e-01 | 0.369 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.275024e-01 | 0.369 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.275024e-01 | 0.369 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.275024e-01 | 0.369 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.275024e-01 | 0.369 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.275024e-01 | 0.369 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 1.366269e-01 | 0.864 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.474063e-02 | 1.072 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 2.091923e-01 | 0.679 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.331602e-02 | 1.030 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.652065e-01 | 0.576 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.652065e-01 | 0.576 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.652065e-01 | 0.576 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.126569e-01 | 0.948 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.865099e-01 | 0.729 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.470834e-01 | 0.460 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.470834e-01 | 0.460 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.470834e-01 | 0.460 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.470834e-01 | 0.460 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.476392e-02 | 1.072 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.382472e-02 | 1.077 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.951970e-01 | 0.530 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.999526e-02 | 1.000 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.563883e-01 | 0.591 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.254209e-01 | 0.647 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.998115e-01 | 0.699 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.056731e-01 | 0.976 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.056731e-01 | 0.976 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.700677e-02 | 1.060 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.392888e-01 | 0.856 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.170692e-01 | 0.663 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.170692e-01 | 0.663 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.807397e-01 | 0.552 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.807397e-01 | 0.552 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.879417e-01 | 0.312 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.879417e-01 | 0.312 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.879417e-01 | 0.312 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.879417e-01 | 0.312 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.879417e-01 | 0.312 | 0 | 0 |
| MPS VI - Maroteaux-Lamy syndrome | R-HSA-2206285 | 4.879417e-01 | 0.312 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.879417e-01 | 0.312 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.879417e-01 | 0.312 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.000774e-01 | 1.000 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.497470e-01 | 0.825 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.054241e-01 | 0.515 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.054241e-01 | 0.515 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.054241e-01 | 0.515 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.054241e-01 | 0.515 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.054241e-01 | 0.515 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.555446e-01 | 0.449 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.555446e-01 | 0.449 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.555446e-01 | 0.449 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.555446e-01 | 0.449 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.555446e-01 | 0.449 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.875670e-01 | 0.541 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.875670e-01 | 0.541 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.253361e-01 | 0.371 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.089665e-01 | 0.510 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.855286e-01 | 0.414 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.855286e-01 | 0.414 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.738206e-01 | 0.563 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.738206e-01 | 0.563 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.553163e-01 | 0.449 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.305763e-01 | 0.481 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.305763e-01 | 0.481 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.596241e-01 | 0.586 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.083567e-01 | 0.511 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.523205e-01 | 0.453 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.803033e-01 | 0.420 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.151715e-01 | 0.382 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 4.151715e-01 | 0.382 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.626063e-01 | 0.335 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.626063e-01 | 0.335 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.420035e-01 | 0.266 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.420035e-01 | 0.266 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.420035e-01 | 0.266 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.420035e-01 | 0.266 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.420035e-01 | 0.266 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.420035e-01 | 0.266 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.888482e-01 | 0.539 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.482252e-01 | 0.458 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.188778e-01 | 0.496 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.677749e-01 | 0.434 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.443378e-01 | 0.352 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.912424e-01 | 0.536 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.984151e-01 | 0.302 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.495015e-01 | 0.457 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.719717e-01 | 0.429 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.069528e-01 | 0.390 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.973539e-01 | 0.401 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.542632e-01 | 0.343 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.403316e-01 | 0.468 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.658929e-01 | 0.437 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.264841e-01 | 0.370 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.606410e-01 | 0.337 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.326559e-01 | 0.274 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.903605e-01 | 0.229 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.903605e-01 | 0.229 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.903605e-01 | 0.229 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.903605e-01 | 0.229 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.903605e-01 | 0.229 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.903605e-01 | 0.229 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 5.903605e-01 | 0.229 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 5.903605e-01 | 0.229 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 5.903605e-01 | 0.229 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 5.903605e-01 | 0.229 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.019273e-01 | 0.299 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.019273e-01 | 0.299 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.019273e-01 | 0.299 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.019273e-01 | 0.299 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.114779e-01 | 0.386 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.114779e-01 | 0.386 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.686996e-01 | 0.329 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.843155e-01 | 0.315 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.250668e-01 | 0.280 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.250668e-01 | 0.280 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.250668e-01 | 0.280 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.891505e-01 | 0.311 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.692332e-01 | 0.329 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.036528e-01 | 0.298 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.541662e-01 | 0.256 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.182623e-01 | 0.285 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.401978e-01 | 0.267 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.401978e-01 | 0.267 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.401978e-01 | 0.267 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.401978e-01 | 0.267 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.697057e-01 | 0.244 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.961929e-01 | 0.225 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.961929e-01 | 0.225 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.336143e-01 | 0.198 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.336143e-01 | 0.198 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.586903e-01 | 0.253 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.759420e-01 | 0.240 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.911250e-01 | 0.228 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.039827e-01 | 0.219 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.039827e-01 | 0.219 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.039827e-01 | 0.219 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.039827e-01 | 0.219 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.232890e-01 | 0.205 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.119021e-01 | 0.213 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.254425e-01 | 0.204 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.254425e-01 | 0.204 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.254425e-01 | 0.204 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.254425e-01 | 0.204 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.223608e-01 | 0.206 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.402712e-01 | 0.194 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.320131e-01 | 0.199 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.320131e-01 | 0.199 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.373644e-01 | 0.196 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.373644e-01 | 0.196 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.118006e-01 | 0.213 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.045949e-01 | 0.516 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.045949e-01 | 0.516 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.482252e-01 | 0.458 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.499511e-01 | 0.824 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.373644e-01 | 0.196 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.045949e-01 | 0.516 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.133543e-01 | 0.946 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.170692e-01 | 0.663 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.830360e-02 | 1.054 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.836564e-01 | 0.736 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.959251e-01 | 0.402 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.264841e-01 | 0.370 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.175641e-01 | 0.930 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.140437e-01 | 0.669 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.741266e-01 | 0.427 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.409597e-01 | 0.467 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.553163e-01 | 0.449 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.292506e-01 | 0.367 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.541662e-01 | 0.256 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.175641e-01 | 0.930 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.022685e-01 | 0.990 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.185173e-01 | 0.209 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.517584e-01 | 0.819 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.091923e-01 | 0.679 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.436436e-01 | 0.613 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.220174e-01 | 0.654 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.697057e-01 | 0.244 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.324393e-01 | 0.878 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.264841e-01 | 0.370 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.862619e-01 | 0.313 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.468302e-01 | 0.460 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.683423e-01 | 0.774 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.011991e-01 | 0.221 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.103774e-01 | 0.957 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.400107e-01 | 0.854 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.254425e-01 | 0.204 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.747018e-01 | 0.241 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.878356e-01 | 0.312 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.245227e-01 | 0.905 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.311835e-01 | 0.275 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.175641e-01 | 0.930 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.499511e-01 | 0.824 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.188778e-01 | 0.496 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.892035e-01 | 0.539 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.286718e-01 | 0.641 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.286718e-01 | 0.641 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.421575e-01 | 0.354 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.842792e-01 | 0.735 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.246755e-01 | 0.648 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.489849e-02 | 1.071 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.065893e-01 | 0.513 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.324958e-01 | 0.634 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.529726e-01 | 0.597 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.253361e-01 | 0.371 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.903558e-01 | 0.537 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.803033e-01 | 0.420 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.443378e-01 | 0.352 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.069528e-01 | 0.390 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.185870e-01 | 0.285 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.070918e-01 | 0.970 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.890500e-01 | 0.723 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.781510e-01 | 0.749 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.781510e-01 | 0.749 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.483428e-01 | 0.605 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.326559e-01 | 0.274 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.054241e-01 | 0.515 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.606410e-01 | 0.337 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.108700e-01 | 0.676 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.709801e-01 | 0.243 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.517584e-01 | 0.819 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.866106e-01 | 0.729 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.652065e-01 | 0.576 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.470834e-01 | 0.460 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.867583e-01 | 0.413 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.879417e-01 | 0.312 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.664560e-01 | 0.574 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.906783e-01 | 0.720 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.420035e-01 | 0.266 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.586712e-01 | 0.587 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.729108e-01 | 0.325 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.392416e-01 | 0.357 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.476741e-01 | 0.261 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.254425e-01 | 0.204 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.254425e-01 | 0.204 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.017099e-01 | 0.695 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.053520e-01 | 0.977 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.053520e-01 | 0.977 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.866106e-01 | 0.729 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.998266e-01 | 0.699 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.185637e-01 | 0.209 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.365494e-01 | 0.626 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.459161e-01 | 0.351 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.514489e-01 | 0.820 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.804831e-02 | 1.009 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.880040e-01 | 0.231 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.786353e-01 | 0.748 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.786353e-01 | 0.748 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.366269e-01 | 0.864 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.652065e-01 | 0.576 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.859369e-01 | 0.731 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.326559e-01 | 0.274 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.880040e-01 | 0.231 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.259347e-01 | 0.487 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.214958e-01 | 0.655 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.531410e-01 | 0.815 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.011991e-01 | 0.221 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.911250e-01 | 0.228 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.126569e-01 | 0.948 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.384950e-01 | 0.358 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.231842e-01 | 0.281 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.433848e-01 | 0.843 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.208225e-01 | 0.918 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.517584e-01 | 0.819 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.441457e-01 | 0.841 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.065893e-01 | 0.513 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.120255e-01 | 0.951 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.126569e-01 | 0.948 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.470834e-01 | 0.460 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.470834e-01 | 0.460 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.470834e-01 | 0.460 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.476392e-02 | 1.072 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.499511e-01 | 0.824 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.499511e-01 | 0.824 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 3.867583e-01 | 0.413 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.626063e-01 | 0.335 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.420035e-01 | 0.266 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.436637e-01 | 0.464 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.873673e-01 | 0.412 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.542632e-01 | 0.343 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.656982e-01 | 0.332 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.652605e-01 | 0.248 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.692332e-01 | 0.329 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.541662e-01 | 0.256 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.011991e-01 | 0.221 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.102434e-01 | 0.214 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.637662e-01 | 0.334 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.546479e-01 | 0.811 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.489262e-01 | 0.457 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.081806e-01 | 0.966 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.499511e-01 | 0.824 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.606410e-01 | 0.337 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.902766e-01 | 0.310 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.626063e-01 | 0.335 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.523205e-01 | 0.453 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.907737e-01 | 0.229 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.539544e-01 | 0.257 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.337066e-01 | 0.198 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.337066e-01 | 0.198 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.337066e-01 | 0.198 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.337066e-01 | 0.198 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.581651e-01 | 0.801 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 3.555446e-01 | 0.449 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.023642e-01 | 0.395 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.611750e-01 | 0.336 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.911250e-01 | 0.228 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.246755e-01 | 0.648 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.066796e-01 | 0.685 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.335091e-01 | 0.874 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.470834e-01 | 0.460 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.350655e-01 | 0.869 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.879417e-01 | 0.312 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.715073e-01 | 0.566 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.903605e-01 | 0.229 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.433341e-01 | 0.265 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.254425e-01 | 0.204 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.345290e-01 | 0.198 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.402712e-01 | 0.194 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.785517e-01 | 0.748 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.930347e-01 | 0.714 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.997892e-01 | 0.699 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.914272e-01 | 0.718 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.914272e-01 | 0.718 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.729108e-01 | 0.325 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.627419e-01 | 0.440 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.656351e-01 | 0.576 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.656351e-01 | 0.576 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.356217e-01 | 0.628 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.930347e-01 | 0.714 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.783066e-01 | 0.320 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.195368e-01 | 0.208 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.274643e-01 | 0.202 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.355728e-01 | 0.868 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.355728e-01 | 0.868 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.036777e-01 | 0.984 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.150487e-01 | 0.502 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.880610e-01 | 0.411 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.938167e-01 | 0.405 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.536221e-01 | 0.257 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.345124e-01 | 0.272 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.555446e-01 | 0.449 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.298637e-01 | 0.367 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.707396e-01 | 0.327 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.155637e-02 | 1.089 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.298637e-01 | 0.367 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.681780e-01 | 0.572 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.725140e-01 | 0.763 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.056731e-01 | 0.976 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.202764e-01 | 0.657 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.083942e-01 | 0.681 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.606779e-01 | 0.337 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.789456e-01 | 0.320 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.937204e-01 | 0.532 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.529726e-01 | 0.597 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.491731e-01 | 0.260 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.214958e-01 | 0.655 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.782739e-01 | 0.749 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.938910e-01 | 0.226 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.999475e-01 | 0.699 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.451486e-01 | 0.838 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.843952e-01 | 0.546 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.843952e-01 | 0.546 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.517584e-01 | 0.819 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.246755e-01 | 0.648 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.599337e-01 | 0.444 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.599337e-01 | 0.444 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.245227e-01 | 0.905 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.663384e-02 | 1.015 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.275024e-01 | 0.369 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.275024e-01 | 0.369 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.275024e-01 | 0.369 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.652065e-01 | 0.576 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.865099e-01 | 0.729 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.056594e-01 | 0.687 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.781510e-01 | 0.749 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.867583e-01 | 0.413 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.879417e-01 | 0.312 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.879417e-01 | 0.312 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.241922e-01 | 0.649 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.253361e-01 | 0.371 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.253361e-01 | 0.371 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.089665e-01 | 0.510 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 3.855286e-01 | 0.414 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.151715e-01 | 0.382 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.420035e-01 | 0.266 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.420035e-01 | 0.266 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.420035e-01 | 0.266 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.389186e-01 | 0.470 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.959251e-01 | 0.402 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.072318e-01 | 0.513 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.984151e-01 | 0.302 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 5.903605e-01 | 0.229 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.903605e-01 | 0.229 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.903605e-01 | 0.229 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.903605e-01 | 0.229 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.611750e-01 | 0.336 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.921308e-01 | 0.308 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.541662e-01 | 0.256 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.961929e-01 | 0.225 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.964718e-01 | 0.224 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 6.039827e-01 | 0.219 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.102434e-01 | 0.214 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.254425e-01 | 0.204 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.027835e-01 | 0.299 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.770658e-01 | 0.752 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.218440e-01 | 0.282 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.022530e-01 | 0.396 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.774597e-01 | 0.321 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.948690e-01 | 0.306 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.318199e-01 | 0.365 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.179939e-01 | 0.286 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.293926e-01 | 0.482 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.027249e-01 | 0.220 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.908046e-01 | 0.309 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.961929e-01 | 0.225 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.823703e-01 | 0.235 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.553163e-01 | 0.449 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.482252e-01 | 0.458 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.903084e-01 | 0.537 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.465283e-01 | 0.189 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.569461e-01 | 0.590 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.919365e-01 | 0.407 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.380570e-01 | 0.623 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.051496e-01 | 0.392 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.609244e-01 | 0.793 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.320131e-01 | 0.199 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.484640e-01 | 0.605 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.264841e-01 | 0.370 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.738206e-01 | 0.563 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.324958e-01 | 0.634 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.832655e-01 | 0.737 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.648844e-01 | 0.783 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.865099e-01 | 0.729 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.470834e-01 | 0.460 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.867583e-01 | 0.413 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.336452e-01 | 0.631 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.151715e-01 | 0.382 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.151715e-01 | 0.382 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.032061e-01 | 0.298 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.566781e-01 | 0.254 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.566781e-01 | 0.254 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.566781e-01 | 0.254 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.311835e-01 | 0.275 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.331602e-02 | 1.030 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.563883e-01 | 0.591 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.001556e-01 | 0.699 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.023642e-01 | 0.395 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.715141e-01 | 0.566 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.318199e-01 | 0.365 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.246755e-01 | 0.648 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.648844e-01 | 0.783 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.951970e-01 | 0.530 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.867583e-01 | 0.413 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.867583e-01 | 0.413 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.833835e-01 | 0.737 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 4.051828e-01 | 0.392 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.805084e-01 | 0.420 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.326559e-01 | 0.274 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.326559e-01 | 0.274 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.326559e-01 | 0.274 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.903605e-01 | 0.229 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.903605e-01 | 0.229 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.961929e-01 | 0.225 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.320131e-01 | 0.199 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.357680e-01 | 0.361 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.696397e-01 | 0.569 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.741863e-01 | 0.759 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.089633e-01 | 0.963 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.016061e-01 | 0.695 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.867583e-01 | 0.413 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.652605e-01 | 0.248 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.400992e-01 | 0.194 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.366269e-01 | 0.864 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.373644e-01 | 0.196 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.443378e-01 | 0.352 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.881977e-01 | 0.230 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.464892e-01 | 0.189 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.017099e-01 | 0.695 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.089665e-01 | 0.510 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.566781e-01 | 0.254 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.729700e-01 | 0.428 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.843952e-01 | 0.546 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.599337e-01 | 0.444 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.866106e-01 | 0.729 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.275024e-01 | 0.369 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 3.470834e-01 | 0.460 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.879417e-01 | 0.312 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.303209e-01 | 0.481 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.569461e-01 | 0.590 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.855286e-01 | 0.414 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.094618e-01 | 0.509 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.626063e-01 | 0.335 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.420035e-01 | 0.266 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.420035e-01 | 0.266 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.420035e-01 | 0.266 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.420035e-01 | 0.266 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.973539e-01 | 0.401 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.392416e-01 | 0.357 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.903605e-01 | 0.229 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.843155e-01 | 0.315 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 5.278992e-01 | 0.277 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.378122e-01 | 0.269 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.336143e-01 | 0.198 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.195368e-01 | 0.208 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.337066e-01 | 0.198 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.331807e-01 | 0.363 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.697057e-01 | 0.244 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.795406e-01 | 0.237 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.805445e-01 | 0.420 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.875670e-01 | 0.541 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.632769e-01 | 0.249 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.582391e-01 | 0.253 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.517584e-01 | 0.819 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.278992e-01 | 0.277 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.652605e-01 | 0.248 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.971357e-01 | 0.224 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.325398e-01 | 0.634 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.669512e-01 | 0.777 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.046874e-01 | 0.297 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.426450e-01 | 0.192 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.656351e-01 | 0.576 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.499511e-01 | 0.824 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.715073e-01 | 0.566 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.253361e-01 | 0.371 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.626063e-01 | 0.335 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.336143e-01 | 0.198 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.707352e-01 | 0.567 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.932835e-01 | 0.227 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.457136e-01 | 0.610 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.457136e-01 | 0.610 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.670481e-01 | 0.435 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.555446e-01 | 0.449 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.589282e-01 | 0.587 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.569754e-01 | 0.340 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.065893e-01 | 0.513 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.470834e-01 | 0.460 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.879417e-01 | 0.312 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.879417e-01 | 0.312 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.879417e-01 | 0.312 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.305763e-01 | 0.481 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.420035e-01 | 0.266 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.420035e-01 | 0.266 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.420035e-01 | 0.266 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.888482e-01 | 0.539 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.501758e-01 | 0.602 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 5.326559e-01 | 0.274 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.903605e-01 | 0.229 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.336143e-01 | 0.198 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.336143e-01 | 0.198 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.336143e-01 | 0.198 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.485458e-01 | 0.188 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.175853e-01 | 0.286 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.960907e-01 | 0.402 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.569754e-01 | 0.340 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.482252e-01 | 0.458 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.246755e-01 | 0.648 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.867583e-01 | 0.413 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.626063e-01 | 0.335 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.903605e-01 | 0.229 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.336143e-01 | 0.198 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.119021e-01 | 0.213 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.254425e-01 | 0.204 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.254425e-01 | 0.204 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.563883e-01 | 0.591 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.392416e-01 | 0.357 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.231842e-01 | 0.281 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.326559e-01 | 0.274 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.253361e-01 | 0.371 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.039827e-01 | 0.219 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.443378e-01 | 0.352 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 5.961929e-01 | 0.225 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.817961e-01 | 0.317 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.729108e-01 | 0.325 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.670116e-01 | 0.246 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.253361e-01 | 0.371 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.841148e-01 | 0.234 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.170692e-01 | 0.663 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.729108e-01 | 0.325 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.039827e-01 | 0.219 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.499675e-01 | 0.187 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.499675e-01 | 0.187 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.499675e-01 | 0.187 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.514398e-01 | 0.186 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.530200e-01 | 0.185 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.530200e-01 | 0.185 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.530200e-01 | 0.185 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.530200e-01 | 0.185 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.530200e-01 | 0.185 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 6.530200e-01 | 0.185 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.530200e-01 | 0.185 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.531140e-01 | 0.185 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.540553e-01 | 0.184 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.540553e-01 | 0.184 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.546665e-01 | 0.184 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.546665e-01 | 0.184 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.582345e-01 | 0.182 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.586688e-01 | 0.181 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.586688e-01 | 0.181 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.596961e-01 | 0.181 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.630241e-01 | 0.178 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.675264e-01 | 0.176 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.701694e-01 | 0.174 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.701694e-01 | 0.174 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.701694e-01 | 0.174 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.701694e-01 | 0.174 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.714834e-01 | 0.173 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.723032e-01 | 0.172 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.723032e-01 | 0.172 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.723032e-01 | 0.172 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.723032e-01 | 0.172 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.723032e-01 | 0.172 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.723032e-01 | 0.172 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.723032e-01 | 0.172 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.723032e-01 | 0.172 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.723032e-01 | 0.172 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.723032e-01 | 0.172 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.723032e-01 | 0.172 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.746963e-01 | 0.171 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.771328e-01 | 0.169 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.771328e-01 | 0.169 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.789522e-01 | 0.168 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.789522e-01 | 0.168 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.789522e-01 | 0.168 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.789522e-01 | 0.168 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.789522e-01 | 0.168 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.789522e-01 | 0.168 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.789522e-01 | 0.168 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.789522e-01 | 0.168 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.789522e-01 | 0.168 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.790467e-01 | 0.168 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.806770e-01 | 0.167 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.854513e-01 | 0.164 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.876493e-01 | 0.163 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.920110e-01 | 0.160 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.920110e-01 | 0.160 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.920110e-01 | 0.160 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.959939e-01 | 0.157 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.029531e-01 | 0.153 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.032790e-01 | 0.153 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.032790e-01 | 0.153 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.032790e-01 | 0.153 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.032790e-01 | 0.153 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.033152e-01 | 0.153 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.033152e-01 | 0.153 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.055089e-01 | 0.151 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.059922e-01 | 0.151 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.063203e-01 | 0.151 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.069088e-01 | 0.151 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.069088e-01 | 0.151 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.069088e-01 | 0.151 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.069088e-01 | 0.151 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.069088e-01 | 0.151 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.069088e-01 | 0.151 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.069088e-01 | 0.151 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.069088e-01 | 0.151 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.069088e-01 | 0.151 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.069088e-01 | 0.151 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.069088e-01 | 0.151 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.069088e-01 | 0.151 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.115560e-01 | 0.148 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.170964e-01 | 0.144 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.170964e-01 | 0.144 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.181478e-01 | 0.144 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.193925e-01 | 0.143 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.193925e-01 | 0.143 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.221152e-01 | 0.141 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 7.221152e-01 | 0.141 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.221152e-01 | 0.141 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.238935e-01 | 0.140 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.254439e-01 | 0.139 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.260504e-01 | 0.139 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.260504e-01 | 0.139 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.260504e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.260504e-01 | 0.139 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.260504e-01 | 0.139 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.260504e-01 | 0.139 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.260504e-01 | 0.139 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.260504e-01 | 0.139 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.260504e-01 | 0.139 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.260504e-01 | 0.139 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.260504e-01 | 0.139 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.260504e-01 | 0.139 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 7.260504e-01 | 0.139 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.260504e-01 | 0.139 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.301301e-01 | 0.137 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.301301e-01 | 0.137 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.305653e-01 | 0.136 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.305653e-01 | 0.136 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.329795e-01 | 0.135 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.339980e-01 | 0.134 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.359735e-01 | 0.133 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.378617e-01 | 0.132 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.378617e-01 | 0.132 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.378617e-01 | 0.132 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.378617e-01 | 0.132 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.378617e-01 | 0.132 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.378617e-01 | 0.132 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.378617e-01 | 0.132 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.378617e-01 | 0.132 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.378617e-01 | 0.132 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.378617e-01 | 0.132 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.378617e-01 | 0.132 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.378617e-01 | 0.132 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.378617e-01 | 0.132 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.378617e-01 | 0.132 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.380163e-01 | 0.132 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.380163e-01 | 0.132 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.423384e-01 | 0.129 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.471789e-01 | 0.127 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.471789e-01 | 0.127 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.473234e-01 | 0.126 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.473234e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.473234e-01 | 0.126 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.473234e-01 | 0.126 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.473234e-01 | 0.126 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.477499e-01 | 0.126 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.477499e-01 | 0.126 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.477499e-01 | 0.126 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.477499e-01 | 0.126 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.477499e-01 | 0.126 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.532189e-01 | 0.123 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.532189e-01 | 0.123 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.534666e-01 | 0.123 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.561268e-01 | 0.121 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.561268e-01 | 0.121 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.576243e-01 | 0.121 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.596478e-01 | 0.119 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.633666e-01 | 0.117 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.635973e-01 | 0.117 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.644364e-01 | 0.117 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.644364e-01 | 0.117 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.644364e-01 | 0.117 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.651193e-01 | 0.116 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.655474e-01 | 0.116 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.655474e-01 | 0.116 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.655474e-01 | 0.116 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.655474e-01 | 0.116 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.655474e-01 | 0.116 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.655474e-01 | 0.116 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.655474e-01 | 0.116 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.655474e-01 | 0.116 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.655474e-01 | 0.116 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.655474e-01 | 0.116 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.655474e-01 | 0.116 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.655474e-01 | 0.116 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.655474e-01 | 0.116 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.671605e-01 | 0.115 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.671605e-01 | 0.115 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.671605e-01 | 0.115 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.677327e-01 | 0.115 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.719420e-01 | 0.112 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.733287e-01 | 0.112 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.798664e-01 | 0.108 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.802136e-01 | 0.108 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.808069e-01 | 0.107 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.815694e-01 | 0.107 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.821701e-01 | 0.107 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.856276e-01 | 0.105 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.856276e-01 | 0.105 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.856276e-01 | 0.105 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.856276e-01 | 0.105 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.867539e-01 | 0.104 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.903105e-01 | 0.102 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.903105e-01 | 0.102 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.903105e-01 | 0.102 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.903105e-01 | 0.102 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.903105e-01 | 0.102 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.903105e-01 | 0.102 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.903105e-01 | 0.102 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.910628e-01 | 0.102 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.912443e-01 | 0.102 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.947431e-01 | 0.100 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.947431e-01 | 0.100 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.947431e-01 | 0.100 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.947431e-01 | 0.100 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.947431e-01 | 0.100 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.951088e-01 | 0.100 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.975254e-01 | 0.098 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.975254e-01 | 0.098 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.975254e-01 | 0.098 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.027928e-01 | 0.095 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.027928e-01 | 0.095 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.027928e-01 | 0.095 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.027928e-01 | 0.095 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.072694e-01 | 0.093 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.088384e-01 | 0.092 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.091511e-01 | 0.092 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.091511e-01 | 0.092 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.121389e-01 | 0.090 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.121389e-01 | 0.090 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.124594e-01 | 0.090 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.124594e-01 | 0.090 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.124594e-01 | 0.090 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.124594e-01 | 0.090 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.124594e-01 | 0.090 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.124594e-01 | 0.090 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.124594e-01 | 0.090 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.124594e-01 | 0.090 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.124594e-01 | 0.090 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.187250e-01 | 0.087 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.187250e-01 | 0.087 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.191655e-01 | 0.087 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.196421e-01 | 0.086 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.201004e-01 | 0.086 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.220331e-01 | 0.085 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.220331e-01 | 0.085 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.223713e-01 | 0.085 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.223713e-01 | 0.085 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.223713e-01 | 0.085 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.223713e-01 | 0.085 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.248986e-01 | 0.084 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.254538e-01 | 0.083 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.254769e-01 | 0.083 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.259730e-01 | 0.083 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.295094e-01 | 0.081 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.304497e-01 | 0.081 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.314399e-01 | 0.080 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.322699e-01 | 0.080 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.322699e-01 | 0.080 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.322699e-01 | 0.080 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.322699e-01 | 0.080 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.322699e-01 | 0.080 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.322699e-01 | 0.080 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.322699e-01 | 0.080 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.322699e-01 | 0.080 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.322699e-01 | 0.080 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.322699e-01 | 0.080 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.322699e-01 | 0.080 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.322699e-01 | 0.080 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.322699e-01 | 0.080 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.322699e-01 | 0.080 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.322699e-01 | 0.080 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.322699e-01 | 0.080 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.322699e-01 | 0.080 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.322699e-01 | 0.080 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.334932e-01 | 0.079 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.334932e-01 | 0.079 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.334932e-01 | 0.079 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 8.334932e-01 | 0.079 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.334932e-01 | 0.079 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.334932e-01 | 0.079 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.334932e-01 | 0.079 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.348016e-01 | 0.078 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.348016e-01 | 0.078 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.348016e-01 | 0.078 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.348016e-01 | 0.078 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.370190e-01 | 0.077 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.371813e-01 | 0.077 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.376586e-01 | 0.077 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.383761e-01 | 0.077 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.397702e-01 | 0.076 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.411413e-01 | 0.075 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.411413e-01 | 0.075 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.455077e-01 | 0.073 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.464749e-01 | 0.072 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.464749e-01 | 0.072 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.471653e-01 | 0.072 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.471653e-01 | 0.072 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.471653e-01 | 0.072 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 8.471653e-01 | 0.072 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.471653e-01 | 0.072 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.482863e-01 | 0.071 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.492452e-01 | 0.071 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.499889e-01 | 0.071 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.499889e-01 | 0.071 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.499889e-01 | 0.071 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.499889e-01 | 0.071 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.499889e-01 | 0.071 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.499889e-01 | 0.071 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.499889e-01 | 0.071 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.499889e-01 | 0.071 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.499889e-01 | 0.071 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.499889e-01 | 0.071 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.499889e-01 | 0.071 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.499889e-01 | 0.071 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.512604e-01 | 0.070 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.512604e-01 | 0.070 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.537310e-01 | 0.069 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.549986e-01 | 0.068 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.574244e-01 | 0.067 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.574244e-01 | 0.067 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.574244e-01 | 0.067 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.584510e-01 | 0.066 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.598081e-01 | 0.066 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.598081e-01 | 0.066 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.598081e-01 | 0.066 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.602708e-01 | 0.065 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.608275e-01 | 0.065 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.608275e-01 | 0.065 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.608275e-01 | 0.065 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.658369e-01 | 0.063 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.658369e-01 | 0.063 | 0 | 0 |
| The activation of arylsulfatases | R-HSA-1663150 | 8.658369e-01 | 0.063 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.658369e-01 | 0.063 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.658369e-01 | 0.063 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.658369e-01 | 0.063 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.658369e-01 | 0.063 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.658369e-01 | 0.063 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.658369e-01 | 0.063 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.658369e-01 | 0.063 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.658369e-01 | 0.063 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.658514e-01 | 0.063 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.664649e-01 | 0.062 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.664649e-01 | 0.062 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.676836e-01 | 0.062 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.676836e-01 | 0.062 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.676836e-01 | 0.062 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.698635e-01 | 0.061 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.698635e-01 | 0.061 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.714865e-01 | 0.060 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.714865e-01 | 0.060 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.714865e-01 | 0.060 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.715945e-01 | 0.060 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.715945e-01 | 0.060 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.729603e-01 | 0.059 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.772857e-01 | 0.057 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.772857e-01 | 0.057 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.783895e-01 | 0.056 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.800115e-01 | 0.056 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.800115e-01 | 0.056 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.800115e-01 | 0.056 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.800115e-01 | 0.056 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.800115e-01 | 0.056 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.800115e-01 | 0.056 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.800115e-01 | 0.056 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.800115e-01 | 0.056 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.800115e-01 | 0.056 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.800115e-01 | 0.056 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.800115e-01 | 0.056 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.800271e-01 | 0.056 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.820971e-01 | 0.054 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.822631e-01 | 0.054 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.822631e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.822631e-01 | 0.054 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.822631e-01 | 0.054 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.822631e-01 | 0.054 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.822631e-01 | 0.054 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.830216e-01 | 0.054 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.862637e-01 | 0.052 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.863838e-01 | 0.052 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.864267e-01 | 0.052 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.893086e-01 | 0.051 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 8.893086e-01 | 0.051 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.893086e-01 | 0.051 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.907793e-01 | 0.050 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.921979e-01 | 0.050 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.921979e-01 | 0.050 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.921979e-01 | 0.050 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.926893e-01 | 0.049 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.926893e-01 | 0.049 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.926893e-01 | 0.049 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.926893e-01 | 0.049 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.926893e-01 | 0.049 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.926893e-01 | 0.049 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.926893e-01 | 0.049 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.926893e-01 | 0.049 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.926893e-01 | 0.049 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.926893e-01 | 0.049 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.928671e-01 | 0.049 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.939963e-01 | 0.049 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.939963e-01 | 0.049 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.940079e-01 | 0.049 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.946500e-01 | 0.048 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.946500e-01 | 0.048 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.946500e-01 | 0.048 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.946500e-01 | 0.048 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.946500e-01 | 0.048 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.946500e-01 | 0.048 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.961372e-01 | 0.048 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.993007e-01 | 0.046 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.996506e-01 | 0.046 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.011190e-01 | 0.045 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.011190e-01 | 0.045 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.013486e-01 | 0.045 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.013486e-01 | 0.045 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.013486e-01 | 0.045 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.013486e-01 | 0.045 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.013486e-01 | 0.045 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.013486e-01 | 0.045 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.013486e-01 | 0.045 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.017060e-01 | 0.045 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.024764e-01 | 0.045 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.024764e-01 | 0.045 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.024764e-01 | 0.045 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.025980e-01 | 0.045 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.036121e-01 | 0.044 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.039409e-01 | 0.044 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.040282e-01 | 0.044 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.040282e-01 | 0.044 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.040282e-01 | 0.044 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.040282e-01 | 0.044 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.040282e-01 | 0.044 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.040282e-01 | 0.044 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.040282e-01 | 0.044 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.040282e-01 | 0.044 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.040282e-01 | 0.044 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.040282e-01 | 0.044 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.043898e-01 | 0.044 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.078156e-01 | 0.042 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.078156e-01 | 0.042 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.078156e-01 | 0.042 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.078384e-01 | 0.042 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.083061e-01 | 0.042 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.086082e-01 | 0.042 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.095039e-01 | 0.041 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.097698e-01 | 0.041 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.097698e-01 | 0.041 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.097735e-01 | 0.041 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.115622e-01 | 0.040 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.128600e-01 | 0.040 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.134213e-01 | 0.039 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.141063e-01 | 0.039 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.141696e-01 | 0.039 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.141696e-01 | 0.039 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.141696e-01 | 0.039 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.141696e-01 | 0.039 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.141696e-01 | 0.039 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.141696e-01 | 0.039 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.141696e-01 | 0.039 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.141696e-01 | 0.039 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.141696e-01 | 0.039 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.141696e-01 | 0.039 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.163718e-01 | 0.038 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.175136e-01 | 0.037 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.175136e-01 | 0.037 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.175136e-01 | 0.037 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.175136e-01 | 0.037 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.200110e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.228993e-01 | 0.035 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.228993e-01 | 0.035 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.228993e-01 | 0.035 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.232399e-01 | 0.035 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.232399e-01 | 0.035 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.232399e-01 | 0.035 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.232399e-01 | 0.035 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.242756e-01 | 0.034 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.246289e-01 | 0.034 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.255492e-01 | 0.034 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.261214e-01 | 0.033 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.267499e-01 | 0.033 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.276291e-01 | 0.033 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.282415e-01 | 0.032 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.287846e-01 | 0.032 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.287846e-01 | 0.032 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.305536e-01 | 0.031 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.311622e-01 | 0.031 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.311622e-01 | 0.031 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.311622e-01 | 0.031 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.313521e-01 | 0.031 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.313521e-01 | 0.031 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.313521e-01 | 0.031 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.313521e-01 | 0.031 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.313521e-01 | 0.031 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.313521e-01 | 0.031 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.313521e-01 | 0.031 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.313521e-01 | 0.031 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.313521e-01 | 0.031 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.313521e-01 | 0.031 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.313521e-01 | 0.031 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.333126e-01 | 0.030 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.342543e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.342543e-01 | 0.030 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.342543e-01 | 0.030 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.342543e-01 | 0.030 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.356006e-01 | 0.029 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.368619e-01 | 0.028 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.371570e-01 | 0.028 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.371570e-01 | 0.028 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.371570e-01 | 0.028 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.371570e-01 | 0.028 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.386075e-01 | 0.028 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.386075e-01 | 0.028 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.386075e-01 | 0.028 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.386075e-01 | 0.028 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.386075e-01 | 0.028 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.386075e-01 | 0.028 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.386075e-01 | 0.028 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.388705e-01 | 0.027 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.393341e-01 | 0.027 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.415139e-01 | 0.026 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.426540e-01 | 0.026 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.426540e-01 | 0.026 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.426540e-01 | 0.026 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.426540e-01 | 0.026 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.428862e-01 | 0.026 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.450964e-01 | 0.025 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.450964e-01 | 0.025 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.450964e-01 | 0.025 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.450964e-01 | 0.025 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.450964e-01 | 0.025 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.450964e-01 | 0.025 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.450964e-01 | 0.025 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.450964e-01 | 0.025 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.450964e-01 | 0.025 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.450964e-01 | 0.025 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.450964e-01 | 0.025 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.450964e-01 | 0.025 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.450964e-01 | 0.025 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.476915e-01 | 0.023 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.476915e-01 | 0.023 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.476915e-01 | 0.023 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.476915e-01 | 0.023 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.476915e-01 | 0.023 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.476915e-01 | 0.023 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.478938e-01 | 0.023 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.483807e-01 | 0.023 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.483807e-01 | 0.023 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.484203e-01 | 0.023 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.496219e-01 | 0.022 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.499793e-01 | 0.022 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.508998e-01 | 0.022 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.508998e-01 | 0.022 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.508998e-01 | 0.022 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.523051e-01 | 0.021 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.523051e-01 | 0.021 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.525020e-01 | 0.021 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.525020e-01 | 0.021 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.534877e-01 | 0.021 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.548854e-01 | 0.020 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.550427e-01 | 0.020 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.560901e-01 | 0.020 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.560901e-01 | 0.020 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.560901e-01 | 0.020 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.560901e-01 | 0.020 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.560901e-01 | 0.020 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.560901e-01 | 0.020 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.560901e-01 | 0.020 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.565283e-01 | 0.019 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.565283e-01 | 0.019 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.565283e-01 | 0.019 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.565283e-01 | 0.019 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.587950e-01 | 0.018 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.596993e-01 | 0.018 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.596993e-01 | 0.018 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.607320e-01 | 0.017 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.607320e-01 | 0.017 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.607320e-01 | 0.017 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.607320e-01 | 0.017 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.607320e-01 | 0.017 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.607320e-01 | 0.017 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.607320e-01 | 0.017 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.613039e-01 | 0.017 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.615241e-01 | 0.017 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.634507e-01 | 0.016 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.634935e-01 | 0.016 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.638102e-01 | 0.016 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.639247e-01 | 0.016 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.641321e-01 | 0.016 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.648834e-01 | 0.016 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.648834e-01 | 0.016 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.648834e-01 | 0.016 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.648834e-01 | 0.016 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.648834e-01 | 0.016 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.648834e-01 | 0.016 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.648834e-01 | 0.016 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.658844e-01 | 0.015 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.666467e-01 | 0.015 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.671536e-01 | 0.015 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.671536e-01 | 0.015 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.671536e-01 | 0.015 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.671536e-01 | 0.015 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.672347e-01 | 0.014 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.683753e-01 | 0.014 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.685961e-01 | 0.014 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.685961e-01 | 0.014 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.685961e-01 | 0.014 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.685961e-01 | 0.014 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.685961e-01 | 0.014 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.685961e-01 | 0.014 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.685961e-01 | 0.014 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.701032e-01 | 0.013 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.701032e-01 | 0.013 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.701032e-01 | 0.013 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.704653e-01 | 0.013 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.705032e-01 | 0.013 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.719166e-01 | 0.012 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.719166e-01 | 0.012 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.719166e-01 | 0.012 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.719166e-01 | 0.012 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.719166e-01 | 0.012 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.719166e-01 | 0.012 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.719166e-01 | 0.012 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.720815e-01 | 0.012 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.727965e-01 | 0.012 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.727965e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.735069e-01 | 0.012 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.737503e-01 | 0.012 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.748861e-01 | 0.011 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.748861e-01 | 0.011 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.748861e-01 | 0.011 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.748861e-01 | 0.011 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.748861e-01 | 0.011 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.748861e-01 | 0.011 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.748861e-01 | 0.011 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.748861e-01 | 0.011 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.748861e-01 | 0.011 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.752547e-01 | 0.011 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.756666e-01 | 0.011 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.773015e-01 | 0.010 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.774974e-01 | 0.010 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.775418e-01 | 0.010 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.775418e-01 | 0.010 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.775418e-01 | 0.010 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.776582e-01 | 0.010 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.778138e-01 | 0.010 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.779079e-01 | 0.010 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.794939e-01 | 0.009 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.795427e-01 | 0.009 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.797008e-01 | 0.009 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.799167e-01 | 0.009 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.799167e-01 | 0.009 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.799167e-01 | 0.009 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.799167e-01 | 0.009 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.799167e-01 | 0.009 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.804458e-01 | 0.009 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.804458e-01 | 0.009 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.804458e-01 | 0.009 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.810666e-01 | 0.008 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.811852e-01 | 0.008 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.811852e-01 | 0.008 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.811852e-01 | 0.008 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.814072e-01 | 0.008 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.814072e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.818508e-01 | 0.008 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.820407e-01 | 0.008 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.820407e-01 | 0.008 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.820407e-01 | 0.008 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.820697e-01 | 0.008 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.825187e-01 | 0.008 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.827427e-01 | 0.008 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.831063e-01 | 0.007 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.831063e-01 | 0.007 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.831063e-01 | 0.007 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.831063e-01 | 0.007 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.839401e-01 | 0.007 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.839401e-01 | 0.007 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.839401e-01 | 0.007 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.845074e-01 | 0.007 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.846541e-01 | 0.007 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.846541e-01 | 0.007 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.854956e-01 | 0.006 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.856388e-01 | 0.006 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.862362e-01 | 0.006 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.862679e-01 | 0.006 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.862679e-01 | 0.006 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.871579e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.871579e-01 | 0.006 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.873378e-01 | 0.006 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.875721e-01 | 0.005 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.879793e-01 | 0.005 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.884885e-01 | 0.005 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.885163e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.885163e-01 | 0.005 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.885163e-01 | 0.005 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.885163e-01 | 0.005 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.892274e-01 | 0.005 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.892441e-01 | 0.005 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.897312e-01 | 0.004 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.897312e-01 | 0.004 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.897912e-01 | 0.004 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.901326e-01 | 0.004 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.906560e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.906560e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.908176e-01 | 0.004 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.908176e-01 | 0.004 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.910914e-01 | 0.004 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.914215e-01 | 0.004 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.917891e-01 | 0.004 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.917891e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.921785e-01 | 0.003 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.922600e-01 | 0.003 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.926579e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.926579e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.926579e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.928469e-01 | 0.003 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.929078e-01 | 0.003 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.929457e-01 | 0.003 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.929457e-01 | 0.003 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.934348e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.934348e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.934539e-01 | 0.003 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.934539e-01 | 0.003 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.935367e-01 | 0.003 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.936049e-01 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.941295e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.941295e-01 | 0.003 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.941295e-01 | 0.003 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.942037e-01 | 0.003 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.951381e-01 | 0.002 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.952410e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.952410e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.953063e-01 | 0.002 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.953601e-01 | 0.002 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.956706e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.956750e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.956890e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.958365e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.961706e-01 | 0.002 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.961785e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.961987e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.961987e-01 | 0.002 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.962473e-01 | 0.002 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.962473e-01 | 0.002 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.966445e-01 | 0.001 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.968335e-01 | 0.001 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.969145e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.969997e-01 | 0.001 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.974233e-01 | 0.001 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.975704e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.976014e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.976263e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.976405e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.978522e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.979114e-01 | 0.001 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.979398e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.980824e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.980824e-01 | 0.001 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.982854e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.982854e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.983357e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.984670e-01 | 0.001 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.984878e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.985624e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.986294e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.986867e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.987002e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.988249e-01 | 0.001 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.988517e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.988517e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.988575e-01 | 0.000 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.989051e-01 | 0.000 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.989733e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.990399e-01 | 0.000 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.990399e-01 | 0.000 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.990399e-01 | 0.000 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.991241e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.991241e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.991381e-01 | 0.000 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.991381e-01 | 0.000 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.992076e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.992169e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.992169e-01 | 0.000 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.992720e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.992864e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.992916e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.993614e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.993861e-01 | 0.000 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.994313e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.994630e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.994779e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.994997e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.995195e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.995252e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.995527e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.995527e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.995527e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.996001e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.996425e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.996472e-01 | 0.000 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.996504e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.996654e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.996759e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.996804e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.997067e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.997142e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.997210e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.997401e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997409e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.997448e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.997697e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997716e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.997730e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.997958e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.998368e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998368e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.998541e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.998541e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998696e-01 | 0.000 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.998716e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998759e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.998819e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998847e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998958e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999037e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999068e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999179e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999213e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999333e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999362e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999399e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999424e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999525e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999603e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999639e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999678e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999707e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999768e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999776e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999776e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999809e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999828e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999845e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999898e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999946e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999950e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999956e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999969e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999971e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999971e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999988e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999990e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999994e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999996e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999998e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular responses to stress | R-HSA-2262752 | 1.043610e-13 | 12.981 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.686740e-13 | 12.571 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.202816e-13 | 12.207 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.906564e-12 | 11.537 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.066125e-12 | 11.151 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.571699e-12 | 11.067 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.742229e-12 | 11.058 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.932967e-10 | 9.714 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.709600e-10 | 9.431 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.870773e-10 | 9.312 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.314328e-09 | 8.636 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.930507e-09 | 8.101 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.311580e-08 | 7.882 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.526227e-08 | 7.816 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.794399e-08 | 7.746 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.051082e-08 | 7.688 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.540476e-08 | 7.595 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.897863e-08 | 7.538 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.798089e-08 | 7.553 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.967889e-08 | 7.401 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.250470e-08 | 7.372 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.065447e-08 | 7.295 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.047250e-08 | 7.218 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.955310e-08 | 7.225 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.397949e-08 | 7.194 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 6.309613e-08 | 7.200 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.974355e-08 | 7.098 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.590926e-08 | 7.018 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.025537e-07 | 6.989 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.025537e-07 | 6.989 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.074946e-07 | 6.969 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.385228e-07 | 6.858 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.464075e-07 | 6.834 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.705705e-07 | 6.768 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.824171e-07 | 6.739 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.252699e-07 | 6.647 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 2.604047e-07 | 6.584 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.784475e-07 | 6.555 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.792917e-07 | 6.554 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.650600e-07 | 6.577 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.929152e-07 | 6.307 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.185069e-07 | 6.285 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.310579e-07 | 6.031 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.021557e-06 | 5.991 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.087976e-06 | 5.963 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.452144e-06 | 5.838 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.538274e-06 | 5.813 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.727538e-06 | 5.763 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.835961e-06 | 5.736 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.343854e-06 | 5.630 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.549402e-06 | 5.594 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.626531e-06 | 5.581 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.769710e-06 | 5.558 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.769710e-06 | 5.558 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.065339e-06 | 5.514 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.380474e-06 | 5.471 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.440941e-06 | 5.463 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.000192e-06 | 5.398 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.563484e-06 | 5.341 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 4.744974e-06 | 5.324 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.955303e-06 | 5.305 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.875611e-06 | 5.231 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.158402e-06 | 5.211 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.649971e-06 | 5.116 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.370427e-06 | 5.133 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.592143e-06 | 5.066 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.313012e-06 | 5.080 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.465056e-06 | 5.072 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.783810e-06 | 5.056 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.025710e-05 | 4.989 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.017175e-05 | 4.993 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.953227e-06 | 5.002 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.025710e-05 | 4.989 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.105234e-05 | 4.957 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.062482e-05 | 4.974 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.056439e-05 | 4.976 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.182301e-05 | 4.927 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.184567e-05 | 4.926 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.284672e-05 | 4.891 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.541730e-05 | 4.812 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.493117e-05 | 4.826 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.581248e-05 | 4.801 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.581248e-05 | 4.801 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.755758e-05 | 4.756 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.109330e-05 | 4.676 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.260141e-05 | 4.646 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.353997e-05 | 4.628 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.470533e-05 | 4.607 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.556826e-05 | 4.592 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.665481e-05 | 4.574 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.852103e-05 | 4.545 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.237328e-05 | 4.490 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.561450e-05 | 4.448 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.652223e-05 | 4.437 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.334585e-05 | 4.363 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.364769e-05 | 4.360 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.880315e-05 | 4.312 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.329677e-05 | 4.273 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.416769e-05 | 4.266 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.778019e-05 | 4.238 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.778019e-05 | 4.238 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.541138e-05 | 4.256 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.611418e-05 | 4.251 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.479041e-05 | 4.261 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.744188e-05 | 4.241 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.937679e-05 | 4.226 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.391291e-05 | 4.194 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.630643e-05 | 4.178 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.175234e-05 | 4.144 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.349382e-05 | 4.134 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.868844e-05 | 4.104 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.124521e-05 | 4.090 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.716623e-05 | 4.060 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.820057e-05 | 4.055 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.498596e-05 | 4.022 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.498596e-05 | 4.022 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.504915e-05 | 4.022 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.498596e-05 | 4.022 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.947948e-05 | 4.048 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.024109e-04 | 3.990 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.049636e-04 | 3.979 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.055350e-04 | 3.977 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.109624e-04 | 3.955 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.128189e-04 | 3.948 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.272154e-04 | 3.895 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.203556e-04 | 3.920 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.279825e-04 | 3.893 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.331402e-04 | 3.876 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.392654e-04 | 3.856 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.400235e-04 | 3.854 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.526997e-04 | 3.816 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.536165e-04 | 3.814 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.536876e-04 | 3.813 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.550920e-04 | 3.809 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.742833e-04 | 3.759 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.742833e-04 | 3.759 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.822284e-04 | 3.739 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.922606e-04 | 3.716 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.843196e-04 | 3.734 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.155745e-04 | 3.666 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.333595e-04 | 3.632 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.371709e-04 | 3.625 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.422949e-04 | 3.616 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.500319e-04 | 3.602 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.585923e-04 | 3.587 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.729997e-04 | 3.564 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.842433e-04 | 3.546 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.932936e-04 | 3.533 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.068268e-04 | 3.513 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.451249e-04 | 3.462 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.451249e-04 | 3.462 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.582428e-04 | 3.446 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.681776e-04 | 3.434 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.681776e-04 | 3.434 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.765399e-04 | 3.424 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.802217e-04 | 3.420 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.855787e-04 | 3.414 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.855787e-04 | 3.414 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.084064e-04 | 3.389 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.206856e-04 | 3.376 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.745648e-04 | 3.324 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.767966e-04 | 3.322 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.915067e-04 | 3.308 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 4.915067e-04 | 3.308 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.816712e-04 | 3.317 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.686671e-04 | 3.329 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.313552e-04 | 3.275 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.445811e-04 | 3.264 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.445811e-04 | 3.264 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.527333e-04 | 3.257 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.588111e-04 | 3.253 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.588111e-04 | 3.253 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.634804e-04 | 3.249 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.650535e-04 | 3.248 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.659170e-04 | 3.247 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.950042e-04 | 3.225 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.027409e-04 | 3.220 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.621358e-04 | 3.179 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 6.656786e-04 | 3.177 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.427114e-04 | 3.192 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.237020e-04 | 3.205 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.940465e-04 | 3.159 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.844848e-04 | 3.165 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.068021e-04 | 3.151 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.068021e-04 | 3.151 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.068021e-04 | 3.151 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.068021e-04 | 3.151 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.068021e-04 | 3.151 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.157799e-04 | 3.145 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.157799e-04 | 3.145 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.299232e-04 | 3.137 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.972553e-04 | 3.098 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.972553e-04 | 3.098 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.046192e-04 | 3.094 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.779215e-04 | 3.057 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.782385e-04 | 3.056 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.818642e-04 | 3.055 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.935196e-04 | 3.049 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.935196e-04 | 3.049 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.321102e-04 | 3.031 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.321102e-04 | 3.031 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.082474e-03 | 2.966 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.043565e-03 | 2.981 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.047520e-03 | 2.980 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.038653e-03 | 2.984 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.603174e-04 | 3.018 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.021156e-03 | 2.991 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.082474e-03 | 2.966 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.925576e-04 | 3.003 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.157186e-03 | 2.937 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.157186e-03 | 2.937 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.189296e-03 | 2.925 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.272012e-03 | 2.896 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.304816e-03 | 2.884 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.394993e-03 | 2.855 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.491907e-03 | 2.826 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.544435e-03 | 2.811 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.544435e-03 | 2.811 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.607695e-03 | 2.794 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.676058e-03 | 2.776 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.703489e-03 | 2.769 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.703489e-03 | 2.769 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.869930e-03 | 2.728 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.913103e-03 | 2.718 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.929688e-03 | 2.715 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.942979e-03 | 2.712 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.942979e-03 | 2.712 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.942979e-03 | 2.712 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.229654e-03 | 2.652 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.298611e-03 | 2.639 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.202959e-03 | 2.657 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.185701e-03 | 2.660 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.298611e-03 | 2.639 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.208569e-03 | 2.656 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.223657e-03 | 2.653 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.298611e-03 | 2.639 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.314999e-03 | 2.635 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.314999e-03 | 2.635 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.047587e-03 | 2.689 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.314999e-03 | 2.635 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.298611e-03 | 2.639 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.333043e-03 | 2.632 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.391744e-03 | 2.621 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.479110e-03 | 2.606 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.543658e-03 | 2.595 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.564425e-03 | 2.591 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.604360e-03 | 2.584 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.679015e-03 | 2.572 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.730383e-03 | 2.564 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.784211e-03 | 2.555 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.899654e-03 | 2.538 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.983375e-03 | 2.525 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.055980e-03 | 2.515 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.055980e-03 | 2.515 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.122086e-03 | 2.506 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.122086e-03 | 2.506 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.294921e-03 | 2.482 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.295507e-03 | 2.482 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.303170e-03 | 2.481 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.303170e-03 | 2.481 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.306209e-03 | 2.481 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.403549e-03 | 2.468 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.418336e-03 | 2.466 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.564773e-03 | 2.448 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.568994e-03 | 2.447 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.682769e-03 | 2.434 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.001577e-03 | 2.398 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.001577e-03 | 2.398 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.172233e-03 | 2.380 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.172233e-03 | 2.380 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.955389e-03 | 2.305 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.572949e-03 | 2.340 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.898338e-03 | 2.310 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.891643e-03 | 2.311 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.891643e-03 | 2.311 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.257108e-03 | 2.371 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.522365e-03 | 2.345 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.572949e-03 | 2.340 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.418803e-03 | 2.355 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.009844e-03 | 2.300 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.496881e-03 | 2.347 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.767961e-03 | 2.322 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.178064e-03 | 2.286 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.338800e-03 | 2.273 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.539250e-03 | 2.257 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 5.735253e-03 | 2.241 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.043244e-03 | 2.219 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.359025e-03 | 2.197 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.443325e-03 | 2.191 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.491684e-03 | 2.188 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.491684e-03 | 2.188 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.491684e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.491684e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.491684e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.491684e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.491684e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.491684e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.491684e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.491684e-03 | 2.188 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.491684e-03 | 2.188 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.067036e-03 | 2.151 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.067036e-03 | 2.151 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 7.067036e-03 | 2.151 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 7.067036e-03 | 2.151 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.097830e-03 | 2.149 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.103208e-03 | 2.149 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.209057e-03 | 2.142 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.281105e-03 | 2.138 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.291054e-03 | 2.137 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.400087e-03 | 2.131 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.507168e-03 | 2.125 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.560863e-03 | 2.121 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.940153e-03 | 2.100 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.940153e-03 | 2.100 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.940153e-03 | 2.100 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.940153e-03 | 2.100 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.870936e-03 | 2.104 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.940153e-03 | 2.100 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.940153e-03 | 2.100 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.146555e-03 | 2.089 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.904286e-03 | 2.102 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.904286e-03 | 2.102 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.940153e-03 | 2.100 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.453933e-03 | 2.073 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.010666e-03 | 2.096 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.225621e-03 | 2.035 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.480587e-03 | 2.023 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.480587e-03 | 2.023 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.516105e-03 | 2.022 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.067349e-02 | 1.972 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.067349e-02 | 1.972 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.080153e-02 | 1.967 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.106632e-02 | 1.956 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.128674e-02 | 1.947 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.177030e-02 | 1.929 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.177997e-02 | 1.929 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.193886e-02 | 1.923 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.206412e-02 | 1.919 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.206412e-02 | 1.919 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.228038e-02 | 1.911 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.234356e-02 | 1.909 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.234356e-02 | 1.909 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.289118e-02 | 1.890 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.301753e-02 | 1.885 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.328773e-02 | 1.877 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.347033e-02 | 1.871 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.435671e-02 | 1.843 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.449129e-02 | 1.839 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.483457e-02 | 1.829 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.493993e-02 | 1.826 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.527661e-02 | 1.816 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.527661e-02 | 1.816 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.527661e-02 | 1.816 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.527661e-02 | 1.816 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.527661e-02 | 1.816 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.569425e-02 | 1.804 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.653408e-02 | 1.782 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.690102e-02 | 1.772 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.717121e-02 | 1.765 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.717121e-02 | 1.765 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.764678e-02 | 1.753 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.786647e-02 | 1.748 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.793272e-02 | 1.746 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.793272e-02 | 1.746 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.793272e-02 | 1.746 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.824266e-02 | 1.739 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.825101e-02 | 1.739 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.841160e-02 | 1.735 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.850955e-02 | 1.733 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.862817e-02 | 1.730 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.876573e-02 | 1.727 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.912646e-02 | 1.718 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.036226e-02 | 1.691 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.254858e-02 | 1.647 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.199253e-02 | 1.658 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.199253e-02 | 1.658 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.113814e-02 | 1.675 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.433448e-02 | 1.614 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.433448e-02 | 1.614 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.400500e-02 | 1.620 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.322584e-02 | 1.634 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.173625e-02 | 1.663 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.977456e-02 | 1.704 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.433448e-02 | 1.614 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.060651e-02 | 1.686 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.977456e-02 | 1.704 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.036226e-02 | 1.691 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.377007e-02 | 1.624 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.333460e-02 | 1.632 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.036226e-02 | 1.691 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.199253e-02 | 1.658 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.963924e-02 | 1.707 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.173625e-02 | 1.663 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.199253e-02 | 1.658 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.995784e-02 | 1.700 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.571669e-02 | 1.590 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.036226e-02 | 1.691 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.631883e-02 | 1.580 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.685365e-02 | 1.571 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.728651e-02 | 1.564 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.776741e-02 | 1.556 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.776741e-02 | 1.556 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.785462e-02 | 1.555 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.787144e-02 | 1.555 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.839249e-02 | 1.547 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.839249e-02 | 1.547 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.849996e-02 | 1.545 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.887042e-02 | 1.540 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.083981e-02 | 1.511 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.108426e-02 | 1.507 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.117521e-02 | 1.506 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.137675e-02 | 1.503 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.162949e-02 | 1.500 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.171208e-02 | 1.499 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.171208e-02 | 1.499 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.171208e-02 | 1.499 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.210883e-02 | 1.493 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.234852e-02 | 1.490 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.234852e-02 | 1.490 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.234852e-02 | 1.490 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 3.333065e-02 | 1.477 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.363541e-02 | 1.473 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.387055e-02 | 1.470 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 3.392991e-02 | 1.469 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.428543e-02 | 1.465 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.528879e-02 | 1.452 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.591926e-02 | 1.445 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.591926e-02 | 1.445 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.658137e-02 | 1.437 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 3.658137e-02 | 1.437 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.684928e-02 | 1.434 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.688181e-02 | 1.433 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.688181e-02 | 1.433 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.829777e-02 | 1.417 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.829777e-02 | 1.417 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.891916e-02 | 1.410 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.891916e-02 | 1.410 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.963345e-02 | 1.402 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.963345e-02 | 1.402 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.046923e-02 | 1.393 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.046923e-02 | 1.393 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.048728e-02 | 1.393 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.048728e-02 | 1.393 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 4.074547e-02 | 1.390 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.074547e-02 | 1.390 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.080200e-02 | 1.389 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.151691e-02 | 1.382 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.255343e-02 | 1.371 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.255343e-02 | 1.371 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.255343e-02 | 1.371 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.261818e-02 | 1.370 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.350483e-02 | 1.361 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.476671e-02 | 1.349 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.542597e-02 | 1.343 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.634474e-02 | 1.334 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.725450e-02 | 1.326 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.725450e-02 | 1.326 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.745107e-02 | 1.324 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.777293e-02 | 1.321 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 4.833246e-02 | 1.316 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.833246e-02 | 1.316 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.884606e-02 | 1.311 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.910379e-02 | 1.309 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.955721e-02 | 1.305 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.985612e-02 | 1.302 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.279081e-02 | 1.277 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.776854e-02 | 1.169 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 6.776854e-02 | 1.169 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 6.776854e-02 | 1.169 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.776854e-02 | 1.169 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.398087e-02 | 1.194 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.398087e-02 | 1.194 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.398087e-02 | 1.194 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.669810e-02 | 1.246 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.669810e-02 | 1.246 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.584279e-02 | 1.181 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.391082e-02 | 1.268 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.051963e-02 | 1.218 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.516415e-02 | 1.124 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.036947e-02 | 1.219 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.300513e-02 | 1.276 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.266579e-02 | 1.278 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.229188e-02 | 1.141 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.312226e-02 | 1.200 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.397007e-02 | 1.194 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.229188e-02 | 1.141 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.756765e-02 | 1.240 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.696808e-02 | 1.244 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.696808e-02 | 1.244 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.696808e-02 | 1.244 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.696808e-02 | 1.244 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.387998e-02 | 1.195 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.321740e-02 | 1.199 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.074371e-02 | 1.295 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.374662e-02 | 1.270 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.074371e-02 | 1.295 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.844492e-02 | 1.233 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.131941e-02 | 1.290 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.169087e-02 | 1.287 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.051963e-02 | 1.218 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.908031e-02 | 1.161 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.279081e-02 | 1.277 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.301867e-02 | 1.276 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 5.669810e-02 | 1.246 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.492338e-02 | 1.125 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.696808e-02 | 1.244 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.516415e-02 | 1.124 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.234711e-02 | 1.141 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.177083e-02 | 1.209 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.537791e-02 | 1.123 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.776854e-02 | 1.169 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.908031e-02 | 1.161 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.934411e-02 | 1.227 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.398087e-02 | 1.194 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.398087e-02 | 1.194 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.756765e-02 | 1.240 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.131941e-02 | 1.290 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.074371e-02 | 1.295 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.254250e-02 | 1.204 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.159080e-02 | 1.287 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.391082e-02 | 1.268 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.541475e-02 | 1.123 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.576031e-02 | 1.121 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.576031e-02 | 1.121 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.576031e-02 | 1.121 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.592050e-02 | 1.120 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.592050e-02 | 1.120 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.603219e-02 | 1.119 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 7.603219e-02 | 1.119 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.603219e-02 | 1.119 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.630313e-02 | 1.117 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 7.970529e-02 | 1.099 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 7.970529e-02 | 1.099 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.009734e-02 | 1.096 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.077394e-02 | 1.093 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.077394e-02 | 1.093 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.117834e-02 | 1.091 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 8.201649e-02 | 1.086 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.320109e-02 | 1.080 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.320109e-02 | 1.080 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.320637e-02 | 1.080 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.444308e-02 | 1.073 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.444308e-02 | 1.073 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.564978e-02 | 1.067 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.643828e-02 | 1.063 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 8.877637e-02 | 1.052 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.899633e-02 | 1.051 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.899633e-02 | 1.051 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.913544e-02 | 1.050 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.913544e-02 | 1.050 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.913544e-02 | 1.050 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.985352e-02 | 1.046 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.985352e-02 | 1.046 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.985352e-02 | 1.046 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.069989e-02 | 1.042 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.069989e-02 | 1.042 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.171147e-02 | 1.038 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.171147e-02 | 1.038 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.197462e-02 | 1.036 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.785859e-02 | 1.009 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.785859e-02 | 1.009 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.807127e-02 | 1.008 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.935943e-02 | 1.003 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.000922e-01 | 1.000 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.006902e-01 | 0.997 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.007703e-01 | 0.997 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.007703e-01 | 0.997 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.012116e-01 | 0.995 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.023719e-01 | 0.990 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.026716e-01 | 0.989 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.026716e-01 | 0.989 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.026716e-01 | 0.989 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.026716e-01 | 0.989 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.026716e-01 | 0.989 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.032434e-01 | 0.986 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.032434e-01 | 0.986 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.032434e-01 | 0.986 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.032434e-01 | 0.986 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.074360e-01 | 0.969 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.074360e-01 | 0.969 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.074360e-01 | 0.969 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.074360e-01 | 0.969 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.081794e-01 | 0.966 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.081794e-01 | 0.966 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.081794e-01 | 0.966 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.082827e-01 | 0.965 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.109768e-01 | 0.955 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.114025e-01 | 0.953 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.114025e-01 | 0.953 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.119690e-01 | 0.951 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.162900e-01 | 0.934 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.167814e-01 | 0.933 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.183002e-01 | 0.927 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.183002e-01 | 0.927 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.183002e-01 | 0.927 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.183002e-01 | 0.927 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.199369e-01 | 0.921 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.200219e-01 | 0.921 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.200219e-01 | 0.921 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.200219e-01 | 0.921 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.225804e-01 | 0.912 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.225804e-01 | 0.912 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.227915e-01 | 0.911 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.228279e-01 | 0.911 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.228279e-01 | 0.911 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.228279e-01 | 0.911 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.254260e-01 | 0.902 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.255223e-01 | 0.901 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.255223e-01 | 0.901 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.255223e-01 | 0.901 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.285792e-01 | 0.891 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.303543e-01 | 0.885 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.309282e-01 | 0.883 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.318855e-01 | 0.880 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.342434e-01 | 0.872 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.351247e-01 | 0.869 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.351247e-01 | 0.869 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.351247e-01 | 0.869 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.696763e-01 | 0.770 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.696763e-01 | 0.770 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.433981e-01 | 0.614 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.433981e-01 | 0.614 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 2.433981e-01 | 0.614 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.433981e-01 | 0.614 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 2.433981e-01 | 0.614 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.433981e-01 | 0.614 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.433981e-01 | 0.614 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.433981e-01 | 0.614 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.433981e-01 | 0.614 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 2.433981e-01 | 0.614 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.388527e-01 | 0.857 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.388527e-01 | 0.857 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.388527e-01 | 0.857 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.711108e-01 | 0.767 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.711108e-01 | 0.767 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.711108e-01 | 0.767 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.044312e-01 | 0.689 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.431623e-01 | 0.844 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.383714e-01 | 0.623 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 2.383714e-01 | 0.623 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.725590e-01 | 0.565 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 2.725590e-01 | 0.565 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 2.725590e-01 | 0.565 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.115291e-01 | 0.675 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.115291e-01 | 0.675 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.685121e-01 | 0.773 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.504275e-01 | 0.823 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.054630e-01 | 0.687 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.603402e-01 | 0.584 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.444817e-01 | 0.612 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.444817e-01 | 0.612 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.288746e-01 | 0.640 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.142622e-01 | 0.669 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.630944e-01 | 0.580 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.998899e-01 | 0.699 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.117498e-01 | 0.674 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.405134e-01 | 0.619 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.542958e-01 | 0.595 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.362415e-01 | 0.627 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.488385e-01 | 0.604 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.488385e-01 | 0.604 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.363428e-01 | 0.865 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.859245e-01 | 0.731 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.859245e-01 | 0.731 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.369483e-01 | 0.625 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.369483e-01 | 0.625 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 1.650971e-01 | 0.782 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.803585e-01 | 0.744 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.954013e-01 | 0.709 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.603402e-01 | 0.584 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.369483e-01 | 0.625 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.510047e-01 | 0.821 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.464971e-01 | 0.834 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.770247e-01 | 0.752 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.758036e-01 | 0.755 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.137208e-01 | 0.670 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.238727e-01 | 0.650 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.638560e-01 | 0.786 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.137208e-01 | 0.670 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.137208e-01 | 0.670 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.398171e-01 | 0.854 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.396901e-01 | 0.620 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.711108e-01 | 0.767 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.638560e-01 | 0.786 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.638560e-01 | 0.786 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.450876e-01 | 0.838 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.999076e-01 | 0.699 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.999076e-01 | 0.699 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.999076e-01 | 0.699 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.479960e-01 | 0.830 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.471975e-01 | 0.832 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.288746e-01 | 0.640 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.669928e-01 | 0.574 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.490912e-01 | 0.827 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.803372e-01 | 0.744 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.758036e-01 | 0.755 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.758036e-01 | 0.755 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.954013e-01 | 0.709 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.059012e-01 | 0.686 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.822619e-01 | 0.739 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.859245e-01 | 0.731 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.822619e-01 | 0.739 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.048922e-01 | 0.688 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.638449e-01 | 0.786 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.723429e-01 | 0.764 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.758036e-01 | 0.755 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.007568e-01 | 0.697 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.048922e-01 | 0.688 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.717891e-01 | 0.765 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.685121e-01 | 0.773 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.338599e-01 | 0.631 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.651221e-01 | 0.782 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.757105e-01 | 0.755 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.857090e-01 | 0.731 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.019434e-01 | 0.695 | 0 | 0 |
| Translation | R-HSA-72766 | 1.855874e-01 | 0.731 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.433981e-01 | 0.614 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.433981e-01 | 0.614 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.388527e-01 | 0.857 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 1.711108e-01 | 0.767 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.115291e-01 | 0.675 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.603402e-01 | 0.584 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.603402e-01 | 0.584 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.522869e-01 | 0.817 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.444817e-01 | 0.612 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.859245e-01 | 0.731 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.859245e-01 | 0.731 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.142622e-01 | 0.669 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.289573e-01 | 0.640 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.269806e-01 | 0.644 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.979756e-01 | 0.703 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.089294e-01 | 0.680 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.567137e-01 | 0.805 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.406322e-01 | 0.619 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 2.206649e-01 | 0.656 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.744912e-01 | 0.758 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.059012e-01 | 0.686 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.591913e-01 | 0.798 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.115291e-01 | 0.675 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.638560e-01 | 0.786 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.369483e-01 | 0.625 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.603402e-01 | 0.584 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.269806e-01 | 0.644 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.269806e-01 | 0.644 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.160022e-01 | 0.666 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.866904e-01 | 0.729 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.592417e-01 | 0.586 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.603402e-01 | 0.584 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.019434e-01 | 0.695 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.711419e-01 | 0.767 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.879395e-01 | 0.726 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.879395e-01 | 0.726 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.879395e-01 | 0.726 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.723429e-01 | 0.764 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.859245e-01 | 0.731 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.859245e-01 | 0.731 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.471975e-01 | 0.832 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.446921e-01 | 0.840 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.374310e-01 | 0.624 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.383714e-01 | 0.623 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.866904e-01 | 0.729 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.201210e-01 | 0.657 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.929185e-01 | 0.715 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.182024e-01 | 0.661 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.491590e-01 | 0.604 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 2.383714e-01 | 0.623 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.879395e-01 | 0.726 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 2.357116e-01 | 0.628 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.411143e-01 | 0.850 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.630944e-01 | 0.580 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.269806e-01 | 0.644 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.112931e-01 | 0.675 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.891406e-01 | 0.723 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.291096e-01 | 0.640 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.054630e-01 | 0.687 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.054630e-01 | 0.687 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.044312e-01 | 0.689 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 2.725590e-01 | 0.565 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.567841e-01 | 0.805 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.750077e-01 | 0.757 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.315371e-01 | 0.635 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.055929e-01 | 0.687 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.383714e-01 | 0.623 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.383714e-01 | 0.623 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.383714e-01 | 0.623 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.725590e-01 | 0.565 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.444817e-01 | 0.612 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.683039e-01 | 0.571 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.803585e-01 | 0.744 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.504275e-01 | 0.823 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.504275e-01 | 0.823 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.363164e-01 | 0.865 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.592417e-01 | 0.586 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.206649e-01 | 0.656 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.683039e-01 | 0.571 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.706853e-01 | 0.768 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.960931e-01 | 0.708 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 1.388527e-01 | 0.857 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.383714e-01 | 0.623 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.725590e-01 | 0.565 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.685121e-01 | 0.773 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.877929e-01 | 0.726 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 1.803585e-01 | 0.744 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.364544e-01 | 0.865 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.444817e-01 | 0.612 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.725590e-01 | 0.565 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.488385e-01 | 0.604 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.638560e-01 | 0.786 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.444817e-01 | 0.612 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.510047e-01 | 0.821 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.054630e-01 | 0.687 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.488385e-01 | 0.604 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.736740e-01 | 0.563 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.746444e-01 | 0.561 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.747662e-01 | 0.561 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.747662e-01 | 0.561 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.747662e-01 | 0.561 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.775006e-01 | 0.557 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.791655e-01 | 0.554 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.825136e-01 | 0.549 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.852765e-01 | 0.545 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.852765e-01 | 0.545 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.852765e-01 | 0.545 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.852765e-01 | 0.545 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.878161e-01 | 0.541 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.905021e-01 | 0.537 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.905021e-01 | 0.537 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.905021e-01 | 0.537 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.968313e-01 | 0.527 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.983760e-01 | 0.525 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.983760e-01 | 0.525 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.055549e-01 | 0.515 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.055549e-01 | 0.515 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.055549e-01 | 0.515 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.064321e-01 | 0.514 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.066828e-01 | 0.513 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.066828e-01 | 0.513 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.066828e-01 | 0.513 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.066828e-01 | 0.513 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.066828e-01 | 0.513 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.066828e-01 | 0.513 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.066828e-01 | 0.513 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.066828e-01 | 0.513 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.066828e-01 | 0.513 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.066828e-01 | 0.513 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.066828e-01 | 0.513 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.103917e-01 | 0.508 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.103917e-01 | 0.508 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.105785e-01 | 0.508 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 3.105785e-01 | 0.508 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.105785e-01 | 0.508 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.105785e-01 | 0.508 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.105785e-01 | 0.508 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.105785e-01 | 0.508 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.105785e-01 | 0.508 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 3.105785e-01 | 0.508 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.105785e-01 | 0.508 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.105785e-01 | 0.508 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.105785e-01 | 0.508 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.105785e-01 | 0.508 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.114412e-01 | 0.507 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.114412e-01 | 0.507 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.120574e-01 | 0.506 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.165353e-01 | 0.500 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.165353e-01 | 0.500 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.224783e-01 | 0.491 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.224783e-01 | 0.491 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.261105e-01 | 0.487 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.263009e-01 | 0.486 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.263009e-01 | 0.486 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.263009e-01 | 0.486 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.355666e-01 | 0.474 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.355666e-01 | 0.474 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.370575e-01 | 0.472 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.404849e-01 | 0.468 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.404849e-01 | 0.468 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.404849e-01 | 0.468 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.404849e-01 | 0.468 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.404849e-01 | 0.468 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.404849e-01 | 0.468 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.404849e-01 | 0.468 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.408847e-01 | 0.467 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.408847e-01 | 0.467 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.408847e-01 | 0.467 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.420053e-01 | 0.466 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.471278e-01 | 0.460 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.548613e-01 | 0.450 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.548613e-01 | 0.450 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.549146e-01 | 0.450 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.593112e-01 | 0.445 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.606921e-01 | 0.443 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.677776e-01 | 0.434 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 3.677776e-01 | 0.434 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.679728e-01 | 0.434 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.679728e-01 | 0.434 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.694181e-01 | 0.432 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.699632e-01 | 0.432 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.712278e-01 | 0.430 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.717973e-01 | 0.430 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.717973e-01 | 0.430 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.717973e-01 | 0.430 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 3.717973e-01 | 0.430 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.717973e-01 | 0.430 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.717973e-01 | 0.430 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.717973e-01 | 0.430 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.717973e-01 | 0.430 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.717973e-01 | 0.430 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.737535e-01 | 0.427 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 3.737535e-01 | 0.427 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.737535e-01 | 0.427 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.856691e-01 | 0.414 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.856691e-01 | 0.414 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.875646e-01 | 0.412 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.959914e-01 | 0.402 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.063169e-01 | 0.391 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.063169e-01 | 0.391 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.063169e-01 | 0.391 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.063169e-01 | 0.391 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.063169e-01 | 0.391 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.069906e-01 | 0.390 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 4.069906e-01 | 0.390 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.094834e-01 | 0.388 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.094834e-01 | 0.388 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.104087e-01 | 0.387 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.104087e-01 | 0.387 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.104087e-01 | 0.387 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.104087e-01 | 0.387 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.104087e-01 | 0.387 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.104087e-01 | 0.387 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.169241e-01 | 0.380 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.197493e-01 | 0.377 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.250627e-01 | 0.372 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.250627e-01 | 0.372 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.250627e-01 | 0.372 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 4.271884e-01 | 0.369 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.275834e-01 | 0.369 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.275834e-01 | 0.369 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 4.275834e-01 | 0.369 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.275834e-01 | 0.369 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.275834e-01 | 0.369 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.275834e-01 | 0.369 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.275834e-01 | 0.369 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.275834e-01 | 0.369 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.275834e-01 | 0.369 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.275834e-01 | 0.369 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 4.275834e-01 | 0.369 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.275834e-01 | 0.369 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.275834e-01 | 0.369 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.282476e-01 | 0.368 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.300420e-01 | 0.366 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.300420e-01 | 0.366 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.300420e-01 | 0.366 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.348312e-01 | 0.362 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.348312e-01 | 0.362 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.348312e-01 | 0.362 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.380383e-01 | 0.358 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.380383e-01 | 0.358 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.380383e-01 | 0.358 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.380383e-01 | 0.358 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.380383e-01 | 0.358 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.380383e-01 | 0.358 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.380383e-01 | 0.358 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 4.394580e-01 | 0.357 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.430275e-01 | 0.354 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.430275e-01 | 0.354 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.430275e-01 | 0.354 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.430275e-01 | 0.354 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.504046e-01 | 0.346 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.588665e-01 | 0.338 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.601135e-01 | 0.337 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.632256e-01 | 0.334 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.662925e-01 | 0.331 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.688105e-01 | 0.329 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.705276e-01 | 0.327 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.705276e-01 | 0.327 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.784185e-01 | 0.320 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 4.784185e-01 | 0.320 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.784185e-01 | 0.320 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.784185e-01 | 0.320 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.784185e-01 | 0.320 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.784185e-01 | 0.320 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 4.784185e-01 | 0.320 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.784185e-01 | 0.320 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.784185e-01 | 0.320 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 4.784185e-01 | 0.320 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.784185e-01 | 0.320 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.785074e-01 | 0.320 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.785074e-01 | 0.320 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.785074e-01 | 0.320 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 4.785074e-01 | 0.320 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.797869e-01 | 0.319 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.824532e-01 | 0.317 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.881334e-01 | 0.311 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.903713e-01 | 0.309 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.903713e-01 | 0.309 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.903713e-01 | 0.309 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.903713e-01 | 0.309 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.970852e-01 | 0.304 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.985519e-01 | 0.302 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.985519e-01 | 0.302 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 4.985519e-01 | 0.302 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.985519e-01 | 0.302 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.000706e-01 | 0.301 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.002202e-01 | 0.301 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.055385e-01 | 0.296 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.055385e-01 | 0.296 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.079592e-01 | 0.294 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.097366e-01 | 0.293 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.131963e-01 | 0.290 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.141132e-01 | 0.289 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.247419e-01 | 0.280 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.247419e-01 | 0.280 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.247419e-01 | 0.280 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.247419e-01 | 0.280 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.247419e-01 | 0.280 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.247419e-01 | 0.280 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.247419e-01 | 0.280 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.247419e-01 | 0.280 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.247419e-01 | 0.280 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.247419e-01 | 0.280 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.247419e-01 | 0.280 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.247419e-01 | 0.280 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.247419e-01 | 0.280 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.247419e-01 | 0.280 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.247419e-01 | 0.280 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.247419e-01 | 0.280 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.247419e-01 | 0.280 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.247419e-01 | 0.280 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.252101e-01 | 0.280 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.272029e-01 | 0.278 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.272029e-01 | 0.278 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.280772e-01 | 0.277 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.290815e-01 | 0.276 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.290815e-01 | 0.276 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 5.290815e-01 | 0.276 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.379858e-01 | 0.269 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.467004e-01 | 0.262 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.468943e-01 | 0.262 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.468943e-01 | 0.262 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.478874e-01 | 0.261 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.478874e-01 | 0.261 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.500315e-01 | 0.260 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.500315e-01 | 0.260 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.500315e-01 | 0.260 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.500315e-01 | 0.260 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.517207e-01 | 0.258 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.547227e-01 | 0.256 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.547227e-01 | 0.256 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.547227e-01 | 0.256 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.547227e-01 | 0.256 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.547227e-01 | 0.256 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.547227e-01 | 0.256 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 5.547227e-01 | 0.256 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.669536e-01 | 0.246 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.669536e-01 | 0.246 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.669536e-01 | 0.246 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.669536e-01 | 0.246 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.669536e-01 | 0.246 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.669536e-01 | 0.246 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.669536e-01 | 0.246 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.669536e-01 | 0.246 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.669536e-01 | 0.246 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.669536e-01 | 0.246 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 5.669536e-01 | 0.246 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.669536e-01 | 0.246 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.669536e-01 | 0.246 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.669536e-01 | 0.246 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.705256e-01 | 0.244 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.713706e-01 | 0.243 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.713706e-01 | 0.243 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.713706e-01 | 0.243 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.713706e-01 | 0.243 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.762176e-01 | 0.239 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.794358e-01 | 0.237 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.810862e-01 | 0.236 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.810862e-01 | 0.236 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.810862e-01 | 0.236 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.810862e-01 | 0.236 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.810862e-01 | 0.236 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.810862e-01 | 0.236 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.810862e-01 | 0.236 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.810862e-01 | 0.236 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.810862e-01 | 0.236 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.839737e-01 | 0.234 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.920698e-01 | 0.228 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.920698e-01 | 0.228 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.930281e-01 | 0.227 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.955436e-01 | 0.225 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.027657e-01 | 0.220 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.054184e-01 | 0.218 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.054184e-01 | 0.218 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.054184e-01 | 0.218 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.054184e-01 | 0.218 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.054184e-01 | 0.218 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 6.054184e-01 | 0.218 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.054184e-01 | 0.218 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.054184e-01 | 0.218 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.054184e-01 | 0.218 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.054184e-01 | 0.218 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.062816e-01 | 0.217 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.062816e-01 | 0.217 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.062816e-01 | 0.217 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.062816e-01 | 0.217 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.086693e-01 | 0.216 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.106876e-01 | 0.214 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.121101e-01 | 0.213 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.121101e-01 | 0.213 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.121101e-01 | 0.213 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.121101e-01 | 0.213 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 6.189085e-01 | 0.208 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 6.189085e-01 | 0.208 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 6.189085e-01 | 0.208 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.303086e-01 | 0.200 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.303086e-01 | 0.200 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.303086e-01 | 0.200 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.303086e-01 | 0.200 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.303086e-01 | 0.200 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.303086e-01 | 0.200 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.303086e-01 | 0.200 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.314779e-01 | 0.200 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.314779e-01 | 0.200 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.314779e-01 | 0.200 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.325228e-01 | 0.199 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.355290e-01 | 0.197 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.355290e-01 | 0.197 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.404687e-01 | 0.194 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.404687e-01 | 0.194 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.404687e-01 | 0.194 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.404687e-01 | 0.194 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.404687e-01 | 0.194 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.404687e-01 | 0.194 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.404687e-01 | 0.194 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.404687e-01 | 0.194 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.404687e-01 | 0.194 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.404687e-01 | 0.194 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.404687e-01 | 0.194 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.501641e-01 | 0.187 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.531757e-01 | 0.185 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 6.531757e-01 | 0.185 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.531757e-01 | 0.185 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.531757e-01 | 0.185 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.531757e-01 | 0.185 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.531757e-01 | 0.185 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.531757e-01 | 0.185 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.531757e-01 | 0.185 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.549311e-01 | 0.184 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.549311e-01 | 0.184 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.549311e-01 | 0.184 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.566717e-01 | 0.183 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.641907e-01 | 0.178 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.664775e-01 | 0.176 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 6.673302e-01 | 0.176 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.689410e-01 | 0.175 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.724074e-01 | 0.172 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.724074e-01 | 0.172 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 6.724074e-01 | 0.172 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 6.724074e-01 | 0.172 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.724074e-01 | 0.172 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.724074e-01 | 0.172 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.724074e-01 | 0.172 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.724074e-01 | 0.172 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 6.724074e-01 | 0.172 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.748996e-01 | 0.171 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.748996e-01 | 0.171 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.748996e-01 | 0.171 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.751330e-01 | 0.171 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.769936e-01 | 0.169 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.797734e-01 | 0.168 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 6.824989e-01 | 0.166 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.827580e-01 | 0.166 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.851931e-01 | 0.164 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.854767e-01 | 0.164 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.854767e-01 | 0.164 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.854767e-01 | 0.164 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 6.955028e-01 | 0.158 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.955028e-01 | 0.158 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.955028e-01 | 0.158 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.955028e-01 | 0.158 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.015105e-01 | 0.154 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.015105e-01 | 0.154 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.015105e-01 | 0.154 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.015105e-01 | 0.154 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.015105e-01 | 0.154 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.015105e-01 | 0.154 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.015105e-01 | 0.154 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.015105e-01 | 0.154 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.021046e-01 | 0.154 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.021046e-01 | 0.154 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.021046e-01 | 0.154 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.021046e-01 | 0.154 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.027770e-01 | 0.153 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.081619e-01 | 0.150 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.086825e-01 | 0.150 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.113584e-01 | 0.148 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.113584e-01 | 0.148 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.150128e-01 | 0.146 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.150128e-01 | 0.146 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.150128e-01 | 0.146 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.150128e-01 | 0.146 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.150128e-01 | 0.146 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.180533e-01 | 0.144 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.180533e-01 | 0.144 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.180533e-01 | 0.144 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.180533e-01 | 0.144 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.182965e-01 | 0.144 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.280298e-01 | 0.138 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.280298e-01 | 0.138 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.280298e-01 | 0.138 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.280298e-01 | 0.138 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.280298e-01 | 0.138 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.280298e-01 | 0.138 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.280298e-01 | 0.138 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.280298e-01 | 0.138 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.280298e-01 | 0.138 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.280298e-01 | 0.138 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 7.280298e-01 | 0.138 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.280298e-01 | 0.138 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.280298e-01 | 0.138 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.280298e-01 | 0.138 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.303221e-01 | 0.136 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 7.303221e-01 | 0.136 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.333307e-01 | 0.135 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.333307e-01 | 0.135 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.334614e-01 | 0.135 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.334614e-01 | 0.135 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.334614e-01 | 0.135 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.334614e-01 | 0.135 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.334614e-01 | 0.135 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.382508e-01 | 0.132 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.449515e-01 | 0.128 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 7.479472e-01 | 0.126 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.479472e-01 | 0.126 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.492000e-01 | 0.125 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.508831e-01 | 0.124 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.508831e-01 | 0.124 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.508831e-01 | 0.124 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.521944e-01 | 0.124 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.521944e-01 | 0.124 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.521944e-01 | 0.124 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.521944e-01 | 0.124 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.521944e-01 | 0.124 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.521944e-01 | 0.124 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.521944e-01 | 0.124 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.521944e-01 | 0.124 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.521944e-01 | 0.124 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.521944e-01 | 0.124 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.562714e-01 | 0.121 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.562714e-01 | 0.121 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.619151e-01 | 0.118 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.619151e-01 | 0.118 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.619151e-01 | 0.118 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.619151e-01 | 0.118 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.672105e-01 | 0.115 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.672105e-01 | 0.115 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.673146e-01 | 0.115 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.673146e-01 | 0.115 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.673146e-01 | 0.115 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.673146e-01 | 0.115 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.742132e-01 | 0.111 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.742132e-01 | 0.111 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.742132e-01 | 0.111 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.742132e-01 | 0.111 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.742132e-01 | 0.111 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.742132e-01 | 0.111 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.742132e-01 | 0.111 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.742132e-01 | 0.111 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.742132e-01 | 0.111 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.742132e-01 | 0.111 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.742132e-01 | 0.111 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.758799e-01 | 0.110 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.777726e-01 | 0.109 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.827944e-01 | 0.106 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.827944e-01 | 0.106 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.827944e-01 | 0.106 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.862621e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.862621e-01 | 0.104 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.879620e-01 | 0.103 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.879621e-01 | 0.103 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.896802e-01 | 0.103 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.942768e-01 | 0.100 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.942768e-01 | 0.100 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.942768e-01 | 0.100 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.942768e-01 | 0.100 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 7.942768e-01 | 0.100 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.942768e-01 | 0.100 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.942768e-01 | 0.100 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.942768e-01 | 0.100 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.942768e-01 | 0.100 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.942768e-01 | 0.100 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.942768e-01 | 0.100 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.942768e-01 | 0.100 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.973618e-01 | 0.098 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 7.973618e-01 | 0.098 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 7.973618e-01 | 0.098 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.977842e-01 | 0.098 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.000728e-01 | 0.097 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.003448e-01 | 0.097 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.072358e-01 | 0.093 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.072447e-01 | 0.093 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.090326e-01 | 0.092 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.110567e-01 | 0.091 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.110567e-01 | 0.091 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.110567e-01 | 0.091 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.110567e-01 | 0.091 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.110567e-01 | 0.091 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.125585e-01 | 0.090 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.125585e-01 | 0.090 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.125585e-01 | 0.090 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.125585e-01 | 0.090 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.125585e-01 | 0.090 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.125585e-01 | 0.090 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.125585e-01 | 0.090 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.125585e-01 | 0.090 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.125585e-01 | 0.090 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.125585e-01 | 0.090 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.125585e-01 | 0.090 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.125585e-01 | 0.090 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.125585e-01 | 0.090 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.125585e-01 | 0.090 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.174465e-01 | 0.088 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.193108e-01 | 0.087 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.228152e-01 | 0.085 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.239190e-01 | 0.084 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.239190e-01 | 0.084 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.239190e-01 | 0.084 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.239190e-01 | 0.084 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.239190e-01 | 0.084 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.239190e-01 | 0.084 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.292167e-01 | 0.081 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.292167e-01 | 0.081 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.292167e-01 | 0.081 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.292167e-01 | 0.081 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.292167e-01 | 0.081 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.292167e-01 | 0.081 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.292167e-01 | 0.081 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 8.292167e-01 | 0.081 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.292167e-01 | 0.081 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.292167e-01 | 0.081 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.329648e-01 | 0.079 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.359885e-01 | 0.078 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.359885e-01 | 0.078 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.359885e-01 | 0.078 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.359885e-01 | 0.078 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.359885e-01 | 0.078 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.428440e-01 | 0.074 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.443953e-01 | 0.073 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.443953e-01 | 0.073 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.443953e-01 | 0.073 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.443953e-01 | 0.073 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.443953e-01 | 0.073 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.443953e-01 | 0.073 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.443953e-01 | 0.073 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.443953e-01 | 0.073 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.443953e-01 | 0.073 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.443953e-01 | 0.073 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.443953e-01 | 0.073 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.443953e-01 | 0.073 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.473046e-01 | 0.072 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.473046e-01 | 0.072 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.473046e-01 | 0.072 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.473046e-01 | 0.072 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.473046e-01 | 0.072 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.480968e-01 | 0.072 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.530998e-01 | 0.069 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.557967e-01 | 0.068 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.573620e-01 | 0.067 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.579058e-01 | 0.067 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.579058e-01 | 0.067 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.579058e-01 | 0.067 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 8.579058e-01 | 0.067 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.582257e-01 | 0.066 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.582257e-01 | 0.066 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.582257e-01 | 0.066 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.582257e-01 | 0.066 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.610307e-01 | 0.065 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.668231e-01 | 0.062 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.675270e-01 | 0.062 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 8.678296e-01 | 0.062 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.678296e-01 | 0.062 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.684637e-01 | 0.061 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.685926e-01 | 0.061 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.694958e-01 | 0.061 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.694958e-01 | 0.061 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.694958e-01 | 0.061 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.708276e-01 | 0.060 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.708276e-01 | 0.060 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.708276e-01 | 0.060 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.708276e-01 | 0.060 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.708276e-01 | 0.060 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.708276e-01 | 0.060 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.708276e-01 | 0.060 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.708276e-01 | 0.060 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.760976e-01 | 0.057 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.774489e-01 | 0.057 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.774489e-01 | 0.057 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.823100e-01 | 0.054 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.823100e-01 | 0.054 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.823100e-01 | 0.054 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.823100e-01 | 0.054 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.823100e-01 | 0.054 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.823100e-01 | 0.054 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.823100e-01 | 0.054 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.826587e-01 | 0.054 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.857908e-01 | 0.053 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.891873e-01 | 0.051 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.909826e-01 | 0.050 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.920735e-01 | 0.050 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.920735e-01 | 0.050 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.920735e-01 | 0.050 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.927724e-01 | 0.049 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.927724e-01 | 0.049 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.927724e-01 | 0.049 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.927724e-01 | 0.049 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.927724e-01 | 0.049 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.927724e-01 | 0.049 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.927724e-01 | 0.049 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.938978e-01 | 0.049 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.938978e-01 | 0.049 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.012965e-01 | 0.045 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.012965e-01 | 0.045 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.014666e-01 | 0.045 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.014666e-01 | 0.045 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.023052e-01 | 0.045 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.023052e-01 | 0.045 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.023052e-01 | 0.045 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.023052e-01 | 0.045 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.023052e-01 | 0.045 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.023052e-01 | 0.045 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.023052e-01 | 0.045 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.023052e-01 | 0.045 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.023052e-01 | 0.045 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.051129e-01 | 0.043 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.060675e-01 | 0.043 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.085289e-01 | 0.042 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.085289e-01 | 0.042 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.085289e-01 | 0.042 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.085289e-01 | 0.042 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.085289e-01 | 0.042 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.109911e-01 | 0.040 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.109911e-01 | 0.040 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.109911e-01 | 0.040 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.109911e-01 | 0.040 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.109911e-01 | 0.040 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.109911e-01 | 0.040 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.109911e-01 | 0.040 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.109911e-01 | 0.040 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.109911e-01 | 0.040 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.109911e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.109911e-01 | 0.040 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.113069e-01 | 0.040 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.123471e-01 | 0.040 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.150660e-01 | 0.039 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.151150e-01 | 0.039 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.151150e-01 | 0.039 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.189052e-01 | 0.037 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.189052e-01 | 0.037 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.189052e-01 | 0.037 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.212535e-01 | 0.036 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.212535e-01 | 0.036 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.220102e-01 | 0.035 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.240628e-01 | 0.034 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.261160e-01 | 0.033 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.261160e-01 | 0.033 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.261160e-01 | 0.033 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.261160e-01 | 0.033 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.261160e-01 | 0.033 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.261160e-01 | 0.033 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.269720e-01 | 0.033 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.269720e-01 | 0.033 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.316954e-01 | 0.031 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.322967e-01 | 0.030 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.322967e-01 | 0.030 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.322967e-01 | 0.030 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.326860e-01 | 0.030 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.326860e-01 | 0.030 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.326860e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.326860e-01 | 0.030 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.326860e-01 | 0.030 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.326860e-01 | 0.030 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.326860e-01 | 0.030 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.326860e-01 | 0.030 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.326860e-01 | 0.030 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.326860e-01 | 0.030 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.327261e-01 | 0.030 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.330383e-01 | 0.030 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.347692e-01 | 0.029 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.361110e-01 | 0.029 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.372523e-01 | 0.028 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.372523e-01 | 0.028 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.383992e-01 | 0.028 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.386722e-01 | 0.027 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.386722e-01 | 0.027 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.386722e-01 | 0.027 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.386722e-01 | 0.027 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.388078e-01 | 0.027 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.396093e-01 | 0.027 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.402617e-01 | 0.027 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.416547e-01 | 0.026 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.418624e-01 | 0.026 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.424492e-01 | 0.026 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.441264e-01 | 0.025 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.441264e-01 | 0.025 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.441264e-01 | 0.025 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.441264e-01 | 0.025 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.441264e-01 | 0.025 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.441264e-01 | 0.025 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.441264e-01 | 0.025 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.478234e-01 | 0.023 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.478234e-01 | 0.023 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.478234e-01 | 0.023 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.490958e-01 | 0.023 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.490958e-01 | 0.023 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.490958e-01 | 0.023 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.490958e-01 | 0.023 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.490958e-01 | 0.023 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.491450e-01 | 0.023 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.501336e-01 | 0.022 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.512608e-01 | 0.022 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.512608e-01 | 0.022 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.520054e-01 | 0.021 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.533779e-01 | 0.021 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.533779e-01 | 0.021 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.536234e-01 | 0.021 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.536234e-01 | 0.021 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.536234e-01 | 0.021 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.536234e-01 | 0.021 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.536234e-01 | 0.021 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.536234e-01 | 0.021 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.536234e-01 | 0.021 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.536234e-01 | 0.021 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.538356e-01 | 0.021 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.538356e-01 | 0.021 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.546550e-01 | 0.020 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.546550e-01 | 0.020 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.546550e-01 | 0.020 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.575105e-01 | 0.019 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 9.577487e-01 | 0.019 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 9.577487e-01 | 0.019 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.577487e-01 | 0.019 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.578567e-01 | 0.019 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.591081e-01 | 0.018 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.604661e-01 | 0.018 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.615071e-01 | 0.017 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.615071e-01 | 0.017 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.620421e-01 | 0.017 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.628486e-01 | 0.016 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.649315e-01 | 0.016 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.649315e-01 | 0.016 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.649315e-01 | 0.016 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.651705e-01 | 0.015 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.661897e-01 | 0.015 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.665913e-01 | 0.015 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.680514e-01 | 0.014 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.687265e-01 | 0.014 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.693706e-01 | 0.014 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.700025e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.700025e-01 | 0.013 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.701169e-01 | 0.013 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.731574e-01 | 0.012 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.732808e-01 | 0.012 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.744028e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.758432e-01 | 0.011 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.774037e-01 | 0.010 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.774305e-01 | 0.010 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.776838e-01 | 0.010 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.779928e-01 | 0.010 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.779928e-01 | 0.010 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.779928e-01 | 0.010 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.799513e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.799513e-01 | 0.009 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.799513e-01 | 0.009 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.817356e-01 | 0.008 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.818744e-01 | 0.008 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.833612e-01 | 0.007 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.834179e-01 | 0.007 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.848422e-01 | 0.007 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.858769e-01 | 0.006 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.859668e-01 | 0.006 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.873237e-01 | 0.006 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.874207e-01 | 0.005 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.884659e-01 | 0.005 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.888000e-01 | 0.005 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.889131e-01 | 0.005 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.895608e-01 | 0.005 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.897758e-01 | 0.004 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.897758e-01 | 0.004 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.904902e-01 | 0.004 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.904902e-01 | 0.004 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.907623e-01 | 0.004 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.919889e-01 | 0.003 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.921084e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.925289e-01 | 0.003 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.928111e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.940346e-01 | 0.003 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.942248e-01 | 0.003 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.944881e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.945659e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.946803e-01 | 0.002 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.946803e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.954909e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.958455e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.958925e-01 | 0.002 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.963444e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.964413e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.965562e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.966383e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.976763e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.977528e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.977582e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.982267e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.982267e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.983848e-01 | 0.001 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.987794e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.988977e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.988977e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.990777e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.991169e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.991599e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.991599e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.993031e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.993031e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.993421e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.993652e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.994218e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.994366e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.994614e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.995632e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.995970e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.996700e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996700e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.996994e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.997316e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.997576e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998117e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998478e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998506e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998577e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.998802e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998895e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.998943e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999234e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999322e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999442e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999492e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999502e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999537e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999665e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999731e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999763e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999801e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999949e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999970e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999972e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999973e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999975e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999979e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999981e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999986e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999989e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999989e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999989e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999996e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |